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Calcium (Ca) is essential for multiple functions within the body including skeletal 
health.  The level of Ca in the serum is tightly regulated.  During periods of habitual low 
Ca intake, the body senses a decrease in serum Ca and increases renal conversion of 25 
hydroxyvitamin D (25(OH)D) to 1,25 dihydroxyvitamin D (1,25(OH)2D).  1,25(OH)2D 
acts through the vitamin D receptor (VDR) to increase intestinal Ca absorption, renal Ca 
reabsorption and skeletal Ca resorption.  Efficient intestinal Ca absorption, especially 
during periods of low Ca intake, is critical for protecting bone mass.  Ca absorption and 
its primary regulator, 1,25(OH)2D, are affected by both genetic and environmental factors. 
However, the genetic architecture of these phenotypes has not been carefully 
studied in a controlled environment.  Using genetically characterized mouse models in a 
controlled environment the studies in this dissertation characterize the natural genetic 
variation affecting intestinal Ca absorption, 25(OH)D, and 1,25(OH)2D under normal and 
low dietary Ca conditions.  This dietary intervention allowed for the study of gene-by-
diet interactions (i.e. variability in the adaptation of these parameters to habitual low Ca 
intake).  The relationship of Ca absorption to known regulators and cellular mediators is 




identifying gaps in our current knowledge of intestinal Ca absorption.  In addition, 
specific genetic loci affecting intestinal Ca absorption, 1,25(OH)2D, 25(OH)D, and diet-
induced adaptation are identified in the mouse genome.  These quantitative trait loci 
(QTLs) represent novel variation affecting Ca absorption and vitamin D metabolites.  
Identification of the causal variation underlying these QTLs will expand our knowledge 
of Ca homeostatic pathways.  These studies serve as a foundation for identification of 









CHAPTER 1. LITERATURE REVIEW 
 
1.1 Introduction 
 Calcium is an essential nutrient that is important for health as a signaling 
molecule and for maintenance of bone health throughout life.  Calcium is maintained at a 
nearly constant concentration in the serum through a complex homeostatic mechanism 
that is sensitive to dietary calcium intake.  The role of diet in maintaining calcium 
homeostasis becomes tremendously important to preserve bone mass, which serves as the 
largest calcium store in the body, but also as structural support for the body.  For this 
reason, the Dietary Reference Intake for calcium is set in order to achieve optimal bone 
health.(1)   
Inadequate calcium intake is common in adolescence, an age where calcium is 
vital for longitudinal growth and attaining peak bone mass.(2)  This dietary inadequacy 
has been shown to increase with age and increase the risk for osteoporosis.(3)  Intestinal 
calcium absorption is an integral part of calcium homeostasis and may also be crucial for 
the prevention of osteoporosis-related fractures.  Calcium absorption is proposed to occur 
through several mechanisms.(4)  The facilitated diffusion model of active intestinal 
calcium absorption responds in an adaptive manner to habitual low calcium intake.  The 




genomic regulation by hormonal vitamin D.  Thus, dietary calcium intake and its 
absorption at the intestine are important regulators of a complex physiological system. 
An emerging factor influencing this system is natural genetic variation.  Genetics 
is known to affect endpoints related to calcium homeostasis such as bone mineral density 
and, more recently, vitamin D status.(5,6)  Recent observations across racial groups 
suggest genetic variation controls calcium absorption efficiency directly, as well as 
adaptation to a low calcium diet (i.e. a gene-by-diet interaction).(7)   
The focus of this thesis is to characterize and locate the natural genetic variation 
affecting calcium homeostasis, specifically intestinal calcium absorption and its primary 
regulator, vitamin D.  Understanding how natural genetic variation affects calcium 
absorption efficiency and its regulation will help us discover new mechanisms of its 
regulation and functional details of the genes involved.  Such research will inform how to 
leverage dietary interventions for maximum health benefit to the individual.  This chapter 
contains a review of the literature focused on calcium absorption physiology and the 
effects of natural genetic variation. 
 
1.2 Calcium Homeostasis 
 
 The Three Tissue Axis 1.2.1
 Calcium functions as both a primary and secondary signal within cells.(8)  
Consequently, maintaining the concentration of this ion within the serum is of vital 
physiological importance.  A complex interplay of environmental cues and hormonal 




resorption from the calcified matrix of the skeleton in order to maintain serum calcium 
concentrations within a tight range of 2.2-2.6 mM.(8)  Calcium absorption at the intestine 
affects both calcium availability and homeostasis.  As such, it is arguably the most 
important component of this three-tissue axis and will be discussed in detail later in this 
chapter.  Reabsorption of calcium from the urine in the kidney occurs in both a passive 
fashion (primarily in the proximal tubule and thick ascending loop of Henle) and an 
active fashion (primarily in the distal convoluted tubule).(9)  The steps and regulation of 
these processes have been well characterized in the kidney.(10-12)  Approximately half of 
all serum ionized calcium is filtered by the kidney, emphasizing its importance for 
maintaining calcium homeostasis.(12)  The skeleton serves as the body’s calcium reserve, 
containing 99% of the body’s total calcium (2).  This calcium reserve serves a dual 
purpose by contributing to the bone mass necessary for structural support of the body.  
However, homeostatic mechanisms will induce bone resorption in order to maintain 
serum calcium concentrations (13).  Calcium intake and absorption at the intestine must 
therefore be sufficient to maintain serum calcium concentration and prevent skeletal 
losses and fracture. 
The importance of adequate calcium absorption for optimal bone health is 
supported by data from both clinical studies and animal models.  Transgenic mice lacking 
a primary regulator of calcium absorption, the vitamin D receptor (VDR), have provided 
valuable lessons on the relationship between calcium absorption and bone health.  These 
mice exhibit greatly decreased bone mineral density, and additional models were able to 
attribute this effect directly to intestinal calcium absorption.(14)   Calcium absorption has 




Calcium absorption efficiency tends to decline with age and this malabsorption has been 
associated with increased hip and vertebral fracture rates.(16,17)  The mechanisms and 
regulation of this critical process will be discussed in the following sections. 
 
 Mechanisms of Intestinal Calcium Absorption 1.2.2
Intestinal calcium absorption has been shown to be composed of a saturable and a 
non-saturable component.(18)  This diversified system allows the intestine to efficiently 
maintain serum calcium homeostasis.  This section will summarize the current state of 
calcium absorption models and discuss observations that suggest our knowledge on this 
topic is still incomplete. 
Passive diffusion, the non-saturable component, is present throughout all sections 
of both the small and large intestine.(19)  Passive diffusion consists of the diffusion of 
small molecules and ions, such as calcium, via a paracellular route between epithelial 
cells according to the electrochemical gradient present in the intestinal lumen.(9,20)  A 
linear relationship of passive calcium absorption to luminal calcium load exists, 
accounting for absorption of 13% of luminal calcium per hour.(21)  Thus, the passive 
component of calcium absorption predominates at normal to high dietary intake levels of 
calcium.(22)  The paracellular route is regulated by tight junctions, which allow the 
intestinal epithelium to be selectively permeable.(23)  Tight junctions are made up of a 
variety of protein families that allow them to be selective based on ion size and 
concentration, similar to ion channels.(24) 
The saturable component of intestinal calcium absorption is a process consisting 




facilitated diffusion of the ion across the enterocyte, and extrusion through the basolateral 
membrane.(22)  Decades of research have characterized the kinetics and regulation of each 
step of this facilitated diffusion model.   
Calcium entry into the enterocyte against the chemical gradient was first 
demonstrated using brush border membrane vesicles in rats and chicks.(25-27)  Several 
paradigms (e.g. membrane channel or carrier) were postulated for calcium entry.(22)  Peng 
et al. cloned the transient receptor potential cation channel, subfamily V, member 6 
(TRPV6) and demonstrated its calcium transport capabilities.(28). 
Once through the brush border membrane, it is necessary to buffer free ionized 
calcium concentrations in the cell and to preserve the slight electrochemical gradient that 
exists within the enterocyte.(22)  A calcium binding protein was isolated from the intestine 
of chicks and several mammalian species.(29,30)  Feher et al. found that diffusion of 
calcium across a dialysis chamber was accomplished only when this calcium binding 
protein, not bovine serum albumin, was added to the buffer.(31)  Active intestinal calcium 
absorption was observed to correlate directly with cytosolic levels of this calcium binding 
protein, suggesting the intercellular trafficking step was the rate-limiting step of active 
calcium absorption.(22,32)  The calcium binding protein, calbindin D9k, was identified as 
the specific protein that accomplishes facilitated diffusion in the enterocyte.(33,34)  After 
being ferried across the enterocyte, calcium must be extruded across the basolateral 
membrane.  Using Ussing chambers, it was demonstrated that this process is ATP 
dependent.(35)  Later, the ATPase PMCA1b was located in chick intestine and found to be 




components make up the facilitated diffusion model of active calcium absorption.  The 
regulation of this model will be discussed in later sections.   
While the facilitated diffusion model is perhaps the most widely accepted model 
of saturable intestinal calcium absorption, several others have been proposed.  One such 
method is vesicular transport, where calcium in the lumen is endocytosed, transported in 
lysosomes, and released as the vesicle merges with the basolateral membrane.(38)  Nemere 
et al. found that lysosomes were filled with Ca45 radioisotope tracer in treated chick 
intestine.(38)  Disruption of the lysosome’s acidic pH gradient resulted in a 67% decrease 
in duodenal calcium transport.(39)  This vesicular movement has been shown to be 
increased by the same regulating factor  as the facilitated diffusion model 
(1,25dihydroxyvitamin D, to be discussed later).(40)  The full mode of regulation and 
impact of vesicular calcium transport is unknown.  Another proposed method of intestinal 
calcium transport is transcaltachia; the rapid, hormone-stimulated induction of calcium 
transport in the intestine.  1,25dihydroxyvitamin D (1,25(OH)2D) hormonal treatment to 
the basolateral side of perfused intestinal membranes increased calcium transport within 
14 minutes.(41)  This non-traditional action of the hormone is proposed to work through 
the membrane associated, rapid response, steroid binding receptor (MARRS) and PKA 
signaling.(42)  The study by Nemere et al. used primary cell culture from intestine-specific 
MARRS knockout mice to show loss of stimulated-calcium transport, but failed to show 
what consequence, if any, this knockout had on whole-body Ca homeostasis and bone 
health.(42) 
Morgan et al. suggested that active calcium absorption is linked to glucose 




through the L-type channel Cav1.3 during the presence of both glucose and sufficient 
calcium.(44)  Morgan et al. observed that perfused rat jejunum absorbed more calcium 
when the perfusate contained glucose rather than mannitol.(43)  Additionally, both glucose 
and calcium absorption were inhibited by an L-type channel inhibitor.(43)  The proposed 
implication of these findings is that they represent a nutrient-sensing mechanism.  
However, there is currently no evidence that it has specificity to calcium or sensitivity to 
overall calcium homeostasis, as the hormonal regulation of the facilitated diffusion model 
does.  The increase in calcium absorption efficiency in rats seen after prolactin treatment 
(45) has been shown to be mediated through Cav1.3 in CaCo2 cells(46).  The physiological 
relevance of this observation remains unclear because prolactin is regulated differently 
between rats and humans.(47) 
 
 Regulation by Dietary Calcium 1.2.3
Dietary calcium intake is a primary regulator of calcium homeostasis.(48)  As 
mentioned above, the intestine plays a vital role in maintaining serum calcium 
concentrations.  However, when dietary intake is insufficient the body must adapt each 
arm of the three tissue axis to maintain serum calcium within the physiologically 
necessary range.  Habitual low dietary calcium intake induces a chain of events that 
activates hormonal regulation.  This mode of regulation and the consequences will be 
discussed in the following sections. 
Although it is a ready source to maintain serum calcium concentration, adaptation 
of bone to a low calcium diet is of particular concern.  Low calcium intake increases risk 




Kalkwarf et al., showed in women that low calcium intake during growth limits the 
attainment of peak bone mass and increases fracture risk later in adulthood.(49)  Calcium 
intake is also important in adulthood to maintain bone mass (i.e. negate bone loss) and 
prevent fracture.(2) Early experiments observed that a calcium deficient diet resulted in 
decreased trabecular bone in cats, suggesting that cancellous bone is more sensitive to 
calcium intake and is the more metabolically active compartment.(50)  This hypothesis is 
supported by a time-course study in rats 70 years later.(51)  However, if the deficient diet 
is maintained, total bone mineral density (BMD) (both trabecular and cortical bone) will 
be affected.(52)  Calcium deficiency limited the increase in BMD during the critical 
pubertal growth period from 35% to 7% in mice.(53) 
Low calcium intake also induces adaptation by increasing the efficiency of 
calcium utilization, primarily by increasing calcium absorption efficiency.  Balance 
studies in rats conducted as early as 1938 suggested that efficiency of calcium utilization 
increased while feeding low calcium diets.(54)  Leichsenring et al. showed that young 
women were more efficient at retaining calcium when maintained on a low calcium diet 
(300mg/d) than when supplemented (1500mg/d).(55)  A population of women with a 
wider age range of intake also exhibited increased calcium retention efficiency on a 
300mg/d compared to a 2000mg/d diet.(56)  Experimental models have shown that the 
efficiency of calcium absorption, specifically, is increased in response to a low calcium 
diet.(18,57)  The inverse relationship between calcium intake and calcium absorption 
efficiency has also been observed in multiple human studies.(58-60)  This physiological 





1.3 The Role of Vitamin D in Calcium Homeostasis 
The importance of vitamin D for calcium homeostasis became apparent as 
disorders associated with the newly discovered vitamin overlapped with abnormalities in 
bone and Ca metabolism.  Rickets, a disease characterized in children by soft, deformed, 
and under-mineralized bone, was found to be ameliorated by sun exposure or increased 
dietary intake of vitamin D.(61)  Ostoeomalacia has a similar etiology to rickets but occurs 
in adulthood as a result of vitamin D deficiency.(13)  As vitamin D metabolites and details 
of its molecular action have been revealed, vitamin D has been recognized as the primary 
regulator of calcium homeostasis. 
 
 Overview of Vitamin D Metabolism 1.3.1
Vitamin D is obtained from the diet (62) or synthesized de novo from 7-
dehydrocholesterol in the skin upon exposure to sunlight (63).  Vitamin D is then 
hydroxylated to 25-hydroxyvitamin D (25(OH)D) in the liver, most likely by the enzyme 
CYP2r1.(64)  25(OH)D serves as the biomarker for vitamin D status in the serum.  
25(OH)D is further hydroxylated at the 1 carbon position by the enzyme 1±-hydroxylase 
(CYP27b1), predominantly in the kidney.(65-67)  This form, 1,25-dihydroxyvitamin D 
(1,25(OH)2D), is the active hormonal form, exerting influence on the kidney, bone, and 
especially the intestine.  Serum 1,25(OH)2D levels are correlated to calcium absorption 
efficiency in both humans and mice.(57,68-70)  1,25(OH)2D binds to the vitamin D receptor 
(VDR) to initiate target gene transcription to maintain whole-body calcium 
homeostasis.(71)  The renal 24-hydroxylase enzyme, CYP24, inactivates hormonal 





The activation of hormonal vitamin D is influenced by calcium homeostasis and 
opposing hormonal signals.  A low serum calcium level is sensed by the calcium sensing 
receptor (CaSR) in the parathyroid gland, signaling release of parathyroid hormone 
(PTH).(48)  PTH increases renal CYP27b1 gene expression and subsequently 1,25(OH)2D 
conversion.(73-75)  The ligand-bound VDR complex then exhibits feedback action by 
binding the promoter of CYP27b1 and inhibiting its expression.(76)  Fibroblast growth 
factor 23 (FGF23) produced by the skeleton also inhibits CYP27b1 expression (and 
therefore 1,25(OH)2D activation) in response to high serum phosphate.
(77)  CYP24 is 
inhibited by PTH in order to promote availability of 1,25(OH)2D.
(72)  1,25(OH)2D 
operates in a feedback loop to greatly increase the gene expression of CYP24, and 
thereby, its own degradation.(78) 
 
 Genetic Disruption of Vitamin D and Calcium Metabolism in Mice 1.3.2
The importance of vitamin D regulation of calcium homeostasis has been illustrated by 
the use of transgenic mice.  Transgenic mouse models disrupt a targeted gene (usually by 
knockout or overexpression) on an otherwise homogenous, inbred background.  This 
method allows for detailed investigation of pathways of interest.   
Three different VDR knockout (KO) mouse models have been reported and used 
for the study of vitamin D function.(79-81)  Studies in each of these models show similar 
results after pups are weaned including hypocalcemia, hypophosphatemia, 
hyperparathyroidism, increased serum 1,25(OH)2D, type II vitamin D-dependent rickets, 




hyperparathyroidism, and type I vitamin D-dependent rickets.(82)  These results 
emphasize that vitamin D action functions primarily to maintain calcium homeostasis.   
These studies, and similar ones, indicate that the intestine is the primary site of 
1,25(OH)2D action to maintain calcium homeostasis.  Intestinal calcium absorption 
efficiency is decreased in VDR KO mice compared to wild-type.(81)  The impact of 
vitamin D on calcium absorption has been assessed using two different strategies.  
Feeding a high-calcium diet containing lactose overrides the impairment of active 
intestinal calcium absorption in VDR null mice.(83,84)  VDR null mice fed this “rescue diet” 
showed normal serum calcium and phosphorus levels and a recovery from the rachitic 
phenotype in bone.(83)  Further investigation on the effects in bone showed normal 
morphology and mineral apposition rate in VDR null mice fed the rescue diet.(84)  These 
observations led the authors to conclude that both the mineral ion homeostasis and bone 
phenotypes of VDR KO mice are due to lack of vitamin D action on intestinal calcium 
absorption.(84)  The second approach to examining the impact of vitamin D-mediated 
intestinal calcium absorption on whole-body calcium homeostasis was to restore 
functionality specifically to this system in a VDR KO mouse model.  Xue et al. 
developed a transgenic mouse model with intestine-specific VDR expression in an 
otherwise VDR null mouse.(85)  Intestinal VDR expression completely recovered the 
negative phenotypes of VDR KO mice, emphasizing the importance of intestinal calcium 
absorption.(85)  
Regulation by serum 1,25(OH)2D allows the intestine to be sensitive to decreases 
in dietary calcium intake.  In wild-type animals, feeding a low calcium diet induces an 
increase in serum 1,25(OH)2D and calcium absorption efficiency.




injection of 1,25(OH)2D induces an increase in calcium absorption efficiency in 
rodents.(19,57)  Adaptation of intestinal calcium absorption to habitual low dietary calcium 
intake occurs through 1,25(OH)2D-mediated up-regulation of the facilitated diffusion 
model.  Gene expression of TRPV6 has been shown to increase in rodents fed a low 
calcium diet or with 1,25(OH)2D injection.
(57,86,87) TRPV6 mRNA is decreased in vitamin 
D deficient rats and VDR KO mice.(81,86)  CaBPD9k gene expression is also regulated by 
1,25(OH)2D genomic action.  CaBPD9k is increased on a low calcium diet or after 
1,25(OH)2D injection 
(57,87,88)  CaBPD9k mRNA and protein are reduced in VDR KO 
mice.(81).  Although typically viewed as less responsive to vitamin D, the basolateral 
transporter, PMCA1b, also responds to vitamin D depletion and repletion.(89)  
Additionally, all three components of the facilitated diffusion model were identified as 
vitamin D target genes in a microarray study conducted in 1,25(OH)2D-injected rats.
(90)   
Although the vitamin D-regulated facilitated diffusion model of intestinal calcium 
absorption appears sound, transgenic mouse models have allowed investigators to explore 
the completeness of this model.  Bianco et al. showed a significant decrease in calcium 
absorption efficiency in TRPV6 KO mice compared to WT mice fed a normal diet.(91)    
However, others presented that calcium absorption in the same TRPV6 KO mice was not 
different from WT mice fed a sufficient calcium diet.(92,93)  Kutuzova et al. write that they 
had changed the background of the null mice developed by Bianco et al. by 3 generations 
of backcrossing to C57BL/6J mice.(92)  Both studies showed that active calcium 
absorption does occur, at some level, without TRPV6, calling into question the validity of 
TRPV6 as a calcium transporter in the enterocyte.  However, this function of TRPV6 was 




hypercalcemia and extensive ectopic calcification.(94)  Additionally, calbindin D9k KO 
mice were shown to be normocalcemic, and exhibited no difference from wild-type in 
calcium absorption.(93,95) 
The roles of TRPV6 and CaBPD9k in low calcium adaptive response have also 
been investigated.  Bianco et al. observed that TRPV6 KO mice had decreased calcium 
absorption compared to WT on both a normal or low calcium diet, suggesting that 
TRPV6 is necessary for intestinal calcium absorption and its adaptation to a low calcium 
diet.(91)  Benn et al. observed that although it did not equal the response of WT mice, 
TRPV6 KO mice were able adapt to a low calcium diet.(93)  Interestingly, 1,25(OH)2D 
injection elicited an equal adaptive response in TRPV6 null and WT mice, suggesting 
that TRPV6 is not necessary for adaptive calcium homeostasis.(92,93)  Lieben et al. 
propose that calcium homeostasis is maintained in TRPV6 knockout mice through 
compensation by the skeleton because TRPV6 KO mice exhibit hyperosteoidosis when 
fed a low calcium diet.(96)   
Studies of CaBPD9k KO mice indicate that this protein is not critical for low 
calcium adaptive response.  CaBPD9k KO mice exhibited an adaptive response equal to 
WT mice on both a low calcium diet and following a 1,25(OH)2D injection.
(93)  A study 
by Lee et al. showed that compensatory up-regulation of calcium transport genes in the 
kidney and intestine may be responsible for the adaptive phenotype of CaBPD9k KO 
mice.(95)  When both TRPV6 and CaBPD9k are knocked out in the same mouse, the 
adaptive response of intestinal calcium absorption to both a low calcium diet and 
1,25(OH)2D injection is markedly reduced.
(93)  However, adaptive calcium absorption is 




Recent studies suggest that vitamin D may also affect passive diffusion of calcium 
in the intestine.  The proposed effect of 1,25(OH)2D on passive diffusion of calcium is 
mediated through increasing ion permeability of tight junction, specifically through 
affecting the proteins claudin 2 and claudin 12.(90,97)  Gene expression and protein levels 
of claudin 2 and claudin 12 are decreased in VDR KO mice.(97) Treatment of intestinal 
cells with 1,25(OH)2D increases gene expression of claudins 2 and 12, resulting in 
increased paracellular movement of calcium.(97) Another mechanism through which 
vitamin D may regulate paracellular movement of calcium is by regulating cell adhesion.  
In a microarray study of rat intestine, 1,25(OH)2D treatment suppressed gene expression 
of cell adhesion proteins cadherin-17 and aquaporin-8.(90)  
Taken together, these observations indicate that our knowledge of intestinal 
calcium absorption is incomplete.  There may be aspects of the facilitated diffusion 
model or compensatory mechanisms that are undiscovered. Alternate methods of 
regulation may also be possible.  The paracellular movement of calcium across the 
intestinal epithelia appears to be more complex than simple passive diffusion along a 
concentration gradient.  The possibility of specificity to calcium and regulation of this 
process by vitamin D warrant further study. 
 
1.4 Genetic Variation and Gene-by-Diet Interactions Influence Calcium Homeostasis 
 
 Overview of Forward Genetic Methodologies 1.4.1
Heritable factors have long been recognized to affect physiology.  Identification 




classes of methods: forward and reverse genetics.  Each method has strengths and 
limitations.  The following section will describe paradigms and challenges of genetic 
studies and how they may be used to inform nutrition research. 
Understanding the function of a gene can be accomplished through manipulation 
of the gene in a model organism and studying the outcome.  This genotype to phenotype 
approach is known as reverse genetics.(98)  Reverse genetics studies include targeted gene 
manipulation (e.g. knockout and transgenic mouse models) as well as examination of 
variation within candidate genes.(99)  These studies are excellent for testing a priori 
hypotheses of the gene’s function in a biological process or pathway.(100)  However, this 
strength is also a weakness in that the study is dependent on, and limited by, existing 
knowledge of the biological pathway or gene.(100)  It has also been suggested that another 
limitation of reverse genetics studies is investigator bias in the development and stringent 
testing of hypotheses.(100) 
These limitations are overcome by forward genetic methods including positional 
cloning, mutagenesis screens, and linkage and association mapping.(99)  Forward genetics 
follows observation of a phenotype to its root genotypic cause(s).(98)  In contrast to 
reverse genetics, forward genetics is hypothesis-free.(100)  This quality of forward genetic 
studies places the emphasis on discovery. Novel genes and regulatory pathways or novel 
roles of known genes can be discovered through forward genetics.(100)  Linkage and 
association mapping methods, in particular, have come to the forefront in recent years 
due to successes in identifying genetic loci related to several types of cancer(101-104), Type 
II diabetes(105), the peripheral nervous system(98), atherosclerosis(106), and skeletal 




wealth of techniques and resources.  The completion of the human(108) and mouse(109) 
genome sequences allow identification of genes, or putative genes, within a locus.  
Further advances have allowed scientists to examine the polymorphisms and gene 
expression patterns of the entire genome.(110,111)  However, the genetic basis of most 
physiological processes is not entirely known. 
Forward genetic methods present several challenges.  Extreme phenotypes may be 
particularly interesting, but these are monogenic, arising from extremely rare mutations 
in a single gene.  The vast majority of physiological processes and diseases are complex, 
polygenic phenotypes.  Therefore, the most common polymorphisms in a population may 
account for only small phenotypic changes, but these effects accumulate to increase risk 
or susceptibility in an individual.  These polymorphisms can create changes in gene 
regulation, expression, and protein function.  Additional challenges of identifying the 
genetic basis of a phenotype include interactions between loci (i.e. epistasis) and the 
modulating influence of environmental factors such as diet. Consequently, identifying 
and characterizing causal genetic loci in the human population is particularly difficult. 
 
 Mouse Models Allow Investigation of Natural Genetic Variation and Gene-by-1.4.2
Diet Interactions 
The mouse has become the ideal model to identify the role of genetic variation in 
biology and disease susceptibility.  Results from genetic mapping studies in mice have 
been shown to be translatable to humans.(112-114)  Similarly, mapping results of similar 
traits in both mice and humans show high concordance.(115)  The natural genetic variation 




humans.(99)  Portions of this variation have been captured in developed populations of 
mice such as recombinant inbred line panels, consomic strains, and congenic strains.  
These mouse models offer a known genetic background with biological replicates 
because each line is inbred.  This attribute allows the investigator to examine how an 
environmental stimulus or stress (e.g. diet) interacts with genetic variation to alter the 
phenotype of interest.(116)  These gene-by-diet interactions are being studied in human 
populations, but do not always reach significance because of the complexity of the human 
environment.  For example, Nettleton et al. examined the effects of whole grain intake 
and an overall healthy diet on previously identified diabetes risk loci, but found only a 
suggestive interaction of diet and genetic risk.(117,118)  In contrast, mouse models under a 
controlled environment and intervention allow identification of gene-by-diet 
interactions.(116)    
Gene-by-diet interactions can affect biology through several paradigms.  
Permissive gene-by-diet interactions are genetic effects only seen under certain dietary 
conditions, typically deficiency.  For example, inactivating mutations in the 
methylenetetrahydrofolate reductase (MTHFR) enzyme reduce conversion of 
homocysteine to methionine.(119)  Jacques et al. observed that the buildup of 
homocysteine in those carrying the MTHFR mutation was further exacerbated a low 
folate status, and suggested those individuals may have a higher folate requirement.(119)  
A gene-by-diet interaction may also be sensitizing, altering the functional outcome of a 
nutrient.  Examples of this type of gene-by-diet interaction are prevalent in lipid 
biology.(120)  Nicklas et al. reported that a low fat, low cholesterol diet had differing 




the APOE4+ genotype was improved, while women with the APOE4- genotype showed 
an increase in serum triglycerides and a large decrease in high-density lipoprotein.(121)  
The following sections will discuss genetic effects on calcium homeostasis phenotypes.  
The evidence for possible gene-by-diet interactions affecting calcium homeostasis will 
also be discussed. 
 
 Genetic Variation Affects Calcium and Bone Metabolism 1.4.3
Much focus has been paid to genetic factors affecting bone health and 
osteoporosis risk.  Evidence collected from family and twin studies, as well as forward 
genetic methods in rodents and humans indicate that bone parameters are highly heritable, 
with heritability values ranging from 50-85%.(5)  Observational twin and family studies 
have noted that genetics contributes to several indices of bone health including; bone size, 
bone mass, BMD, femur geometry, and strength.(122-125)   
There are notable cases of rare, monogenic disorders that lead to extreme bone 
phenotypes.  Candidate gene studies of affected families and knockout mouse models 
have identified COL1A1 and several other genes to be responsible for the bone-fragility 
disease osteogenesis imperfecta.(126)  Interestingly, separate phenotypes were mapped to 
the genomic region containing the lipoprotein-related protein 5 (LRP5) gene.  Linkage 
mapping by Johnson et al. led to identification of LRP5 mutations that  were responsible 
for familial high bone density phenotypes.(127)  Mapping conducted in families with 
fragile, low bone mass osteoporosis pseudoglioma also indicated LRP5 as the causative 
gene.(128)  Linkage mapping followed by positional cloning found SOST mutations to be 




enhanced our knowledge of bone biology, but still do not account for the large 
heritability of bone parameters in the general population. 
The majority of variation in bone phenotypes observed in the general population 
is due to polygenic effects which, individually, are too small to be tracked through a 
single pedigree. This variation can be seen at the population level.  It has been observed 
that racial groups (a surrogate for population structure and genetic variation) differ in 
bone density and strength parameters.(132,133)  Similarly, bone density varies greatly across 
inbred mouse strains.(134)  These populations display a distribution of a quantitative trait 
of interest, such as bone mineral density (BMD), indicating the trait is due to the 
contribution of many different factors, genetic and environmental. 
Forward genetic approaches have been applied in diverse populations to 
successfully identify the more common, small-effect variation affecting bone traits.  
Linkage mapping in mice has identified many regions of the mouse genome linked to 
bone parameters.(135,136)  Fewer studies, however, have been able to identify the candidate 
gene within these regions.  Klein and colleagues identified a region of mouse 
chromosome 11 controlling the natural variation in peak whole body and femoral BMD 
between C57BL/6J and DBA/2 mice.(137)  Further studies using congenic fine mapping 
and differential gene expression analysis indicated the gene driving changes in BMD was 
Alox15, a gene that encodes the 12/15-lipoxygenase important for peroxisome 
proliferator-activated receptor gamma (PPAR³ ) signaling in osteoblast differentiation.(138)  
A cross between C57BL/6J mice and CAST/EiJ mice identified significant linkage 
between distal chromosome 1 and BMD which was attributable to variation in the 




morphology in mice and found that variation in cadherin 11 (Cdh11) significantly 
affected femur width.(140)   
 Recently, genome-wide association studies (GWAS) have been used to identify 
genetic polymorphisms associated with bone traits in humans.(107)  GWAS are hampered 
by the extremely large sample size they require, hidden structure in the chosen population 
(which increases the chance for false positives), and the inability to fully account for 
environmental differences.(141)  The results of available bone-related GWAS and mouse 
linkage studies were overlaid in 2010, showing that 26 out of 28 loci identified in human 
GWAS were also identified in mice.(115)  Thus, there is high concordance between the 
two species in both the genomes and susceptibility to complex diseases (e.g. 
osteoporosis), allowing genetic studies in mice to inform the biology of humans.(141,142) 
 Another important factor to calcium homeostasis, vitamin D status, has been 
shown to be heritable and altered by genetic factors.  Serum 25(OH)D has been shown to 
vary across racial groups, mostly owing to differences in skin tone (i.e. 
Whites>Hispanics>Blacks).(143)  However, heritability of 25(OH)D was shown to differ 
between similar Hispanic American populations, suggesting genetic factors beyond skin 
color influence vitamin D status.(144)  Heritability estimates for serum 25(OH)D range 
from 23-80%.(144-149)  The genetic potential of an individual becomes most important 
when environmental factors, such as sunlight exposure, are at a minimum.  Some of the 
largest heritability estimates of 25(OH)D were measured in winter, when the 
environmental effect of sunlight does not play a large role.(146,147)  Serum 1,25(OH)2D has 
also been shown to be heritable, though not to the extent of 25(OH)D.  Heritability of 




Americans, and 30% in European populations.(144,149)  There are few studies examining 
the genetic determinants of serum 25(OH)D.  Such studies of serum 1,25(OH)2D are 
extremely limited, possibly due to the myriad of physiological and environment also 
influencing it. 
 Recent associations between vitamin D and multiple health outcomes have led to 
increased interest in defining the genetic architecture of vitamin D biology.(150)  
Engelman et al. examined the relationship of serum 25(OH)D and 1,25(OH)2D to 
polymorphisms in three vitamin D candidate genes; vitamin D binding protein (GC), 
CYP27B1, and VDR. Only GC showed significant association, with one SNP affecting 
both 25(OH)D and 1,25(OH)2D levels, and another SNP associated with 25(OH)D 
only.(144)  Another candidate gene study by Bu et al. tested for relationships between 
25(OH)D status and SNPs in nine candidate genes known to affect vitamin D; alkaline 
phosphatase (ALPL), CYP24A1, CYP27A1, CYP27B1, CYP2R1, CYP3A4, GC, VDR, 
and PTH.(151)  The investigators identified and replicated associations between CYP2R1 
and GC polymorphisms that were associated with serum 25(OH)D levels in two 
Caucasian populations.(151)   
 Forward genetics methods have been applied to understanding genetic variability 
on vitamin D metabolites in two clinical studies.  Wjst et al. sought to identify genetic 
regions linked to either serum 25(OH)D or 1,25(OH)2D in German and Swedish families 
with asthma.(149)  This study found that serum 25(OH)D levels were more highly heritable 
than 1,25(OH)2D, 80% and 30%, respectively.
(149)  Five loci were significantly linked to 
serum 25(OH)D in this population, but no previously known vitamin D-related genes 




GWAS of serum 25(OH)D in over 4000 individuals of European descent.(150)  Ahn et al. 
identified single nucleotide polymorphism in only one gene, GC, to be significantly 
associated with serum 25(OH)D.(150)  Three other genes contained variation putatively 
associated with vitamin D status; 7-dehydrocholesterol reductase (DHCR7), acyl-
Coenzyme A dehydrogenase (ACADSB), and CYP2R1.(150)   
 These studies reaffirm relationships seen in candidate gene studies, but also 
indicate that unknown genetic factors affecting vitamin D biology do exist.  Surprisingly, 
the use of animal models to unravel these questions is largely absent.  Natural variation 
was noted in the susceptibility of different dog breeds to rickets in some of the earliest 
studies of vitamin D physiology.(152)  More recently, a screen of 18 inbred mouse lines 
identified significant variation in serum 25(OH)D.(153)  Despite animal models being used 
extensively to characterize vitamin D biology and the genetics of bone health (as 
discussed earlier), they have not been leveraged to identify the genetic factors influencing 
vitamin D metabolites. 
 There are indications that calcium absorption is affected by genetic variation, but 
the factors influencing it have not been well studied.  A wide amount of variation has 
been observed in human populations.  Heaney et al. observed a range of 0.05-0.65 in true 
fractional calcium absorption in four combined populations of postmenopausal, non-
osteoporotic women, even after adjustment for dietary calcium intake.(154)  Wolf et al. 
observed a range of 0.17-0.58 in true fractional calcium absorption.(155)  Several 
environmental factors are commonly associated with intestinal calcium absorption 
efficiency, including age, estrogen, calcium intake, and serum 1,25(OH)2D.
(70,155,156)  Still 




efficiency such as fat, fiber, and protein.(155,157,158)  However, these environmental factors 
and others explain 25%, at most, of the variation seen in calcium absorption.(155,157)  It 
could be hypothesized that genetics makes up the remaining variation.  This idea is 
supported by several pieces of evidence.   
 Similar to BMD, calcium absorption has been observed to vary by race.(60,159-161)  
Abrams et al. observed significantly higher fractional calcium absorption in black than 
white pre and postmenarchal girls.(159)  Several balance and kinetic studies in black and 
white adolescent girls conducted by Dr. Connie Weaver’s research group have confirmed 
this observation under controlled dietary conditions.(60,160,161)  Chinese adolescent girls 
were also observed to have higher calcium absorption efficiency across a range of 
controlled calcium intakes.(59)   
 It has been postulated that polymorphisms in the VDR, specifically, may account 
for the variation seen in intestinal calcium absorption.  However, these candidate gene 
studies have been largely inconclusive and dependent on the haplotype or population 
studied.  Several studies have found a positive association between VDR polymorphisms 
and calcium absorption (162-164), while others found no association at all (155,165-167).  These 
discrepancies may be due to uncontrolled environmental factors, such as dietary calcium 
intake. 
 
 Do Gene-by-diet interactions Influence Calcium Homeostasis? 1.4.4
 As discussed above, calcium homeostasis is sensitive to dietary calcium intake 
which prompts a complex network of physiological and hormonal signals.  Thus, gene-




interactions is particularly evident in skeletal health.  Observed differences in 
heritabilities of bone mass between monozygotic and dizygotic twins increase with age, 
suggesting bone is affected by interaction of genetics and accumulated environmental 
exposures (e.g. diet).(123)  Specific examples of gene-by-diet interactions affecting bone 
have been shown.   
 Farrow et al. identified a permissive gene-by-diet interaction between mutations 
in FGF23 and iron status.(168)  Mutations in a proteolytic cleavage site of FGF23 result in 
inappropriate maintenance of intact, active serum FGF23 and the disease autosomal 
dominant hypophosphatemic rickets (ADHR).(169)  Low iron status increases gene 
expression of FGF23.  Individuals carrying the mutant allele cannot compensate for this 
increase because the mutation inhibits the degradation of FGF23. (168)  Thus, intact 
FGF23 is increased during periods of low iron status, causing the hypophosphatemia and 
osteomalacia that characterize ADHR. (168)  A sensitizing interaction between PPARG 
and dietary fat has also been observed to affect skeletal health.  Ackert-Bicknell et al. 
identified PPARG as a candidate gene modifying bone mineral density between C3H/HeJ 
and C57BL/6J mice.(112)  The effect of this genetic variation on BMD was found to be 
modulated by dietary fat intake. (112)  The authors were also able to identify variation in 
PPARG that influenced BMD in the Framingham Offspring Cohort. (112)  In this 
population, certain SNPs showed significant interactions with dietary fat intake; a high 
fat diet was detrimental to BMD in one genotypic class and beneficial to BMD in the 
other genotypic class.(112)  These studies emphasize the impact of natural genetic 




 Evidence suggests that gene-by-diet interactions influence calcium absorption as 
well.  The adaptive increase in intestinal calcium absorption caused by habitual low 
dietary calcium intake is different among racial groups.  Data from Black and White 
adolescent girls indicate that Black girls display the predicted adaptive increase in 
calcium absorption with decreasing dietary calcium levels, but White girls do not.(161)  
Similarly, Chinese-American girls have higher calcium absorption efficiencies than white 
girls.(59).  The disparity between these racial groups is greater at low calcium intakes, 
supporting the hypothesis that a gene-by-diet (calcium) interaction influencing intestinal 
calcium absorption efficiency exists.(59)   
 The genomic sources of this gene-by-diet interaction are not currently known.  
Candidate gene studies have attempted to relate VDR polymorphisms with calcium 
absorption efficiency, but do not always factor in the effect of dietary calcium.(165)  
Dawson-Hughes et al. examined calcium absorption efficiency in postmenopausal 
women genotyped for the BSM1 VDR polymorphism.(170)  Results of that experiment 
showed calcium absorption efficiency was similar between genotypic classes on a high 
calcium diet, but differed significantly on a low calcium diet.(170)  Specifically, the BB 
genotype showed decreased adaptation to a low calcium diet than the bb genotype.(170)  
Wishart et al. found no associations between the BSM1, APA1 and Taq1 polymorphisms 
and calcium absorption efficiency until the population was corrected for dietary calcium 
intake, serum 1,25(OH)2D, and body weight.
(162)  Thus, the effect of VDR genotype on 
intestinal calcium absorption efficiency is dependent on the dietary and physiological 




Characterization of the gene-by-diet interaction affecting adaptation of calcium 
absorption to a low calcium diet is needed.  However, candidate genes studies such as the 
ones described above are unlikely to reveal the genetic root of gene-by-diet interactions 
because they are limited to what is known about genomic control of the trait of interest, 
and by how completely environmental exposure can be ascertained.  Controlled, 
discovery-focused research is needed to identify what genetic factors allow some 
individuals a genetic advantage to protect their bone while on a low calcium diet while 
others are susceptible to this dietary deficiency. 
 
1.5 Gaps Remain in Our Understanding of Calcium Homeostasis and Its Regulation 
 Considerable research has gone into the molecular mechanisms involved in 
intestinal calcium absorption.  Careful characterization in animal models has led to the 
development of the facilitated diffusion model of active intestinal calcium absorption.  
This model has been shown to be regulated by 1,25(OH)2D in response to low dietary 
calcium intake.  However, the 1,25(OH)2D-mediated facilitated diffusion model does not 
solely and completely explain intestinal calcium absorption.  For instance, considerable 
calcium absorption capacity remains in knockout mouse models of two facilitated 
diffusion components, TRPV6 and CaBPD9k.  Calcium absorption in these mice was still 
able to respond to 1,25(OH)2D.  Additionally, the strong relationship between intestinal 
calcium absorption and 1,25(OH)2D seen in cell and wild-type animal models is not seen 
in human populations.  These observations suggest that there are still details of calcium 
absorption to be discovered.  Particularly, novel mechanisms of regulation by vitamin D 




Observations in racial groups indicate that natural genetic variation may influence 
calcium absorption efficiency.  Although genetic approaches have been used to study 
related phenotypes such as bone mineral density and vitamin D status, the effect of 
genetics of calcium absorption has not been widely studied.  Candidate gene approaches 
have explained little, and are limited to current gene function and pathway knowledge.  
No discovery-focused forward genetic methods have been used to identify genetic 
variation affecting intestinal calcium absorption.  The adaptation of calcium absorption to 
habitual low dietary calcium intake appears to have a genetic component as well, but this 
has not been investigated in depth.  Again, candidate gene studies have had limited 
success explaining this gene-by-diet interaction.  These studies were conducted in human 
populations with little to no control over the environment and other genetic factors.  
Forward genetic studies are needed to identify the genetic sources of this gene-by-diet 
interaction.  Animal models are best suited to this purpose because of their known genetic 
background and the ability of the investigator to control and manipulate the dietary 
environment. 
 The goal of this thesis is to address several of these gaps in our knowledge of 
calcium homeostasis.  Inbred mouse lines were chosen as a research model in order to 
control environment and genetic background.  The first research goal was to characterize 
the natural genetic variation present in intestinal calcium absorption and vitamin D 
metabolites in the laboratory mouse population.  The adaptive response of these 
parameters to a low calcium diet was also assessed.  The second goal was to use forward 




metabolites.  Gene-by-diet interaction loci were also mapped to identify genetic loci 
affecting the response to a low calcium diet. 
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Dietary calcium (Ca) intake is needed to attain peak bone mineral density (BMD). 
Habitual low Ca intake increases intestinal Ca absorption efficiency to protect bone mass 
but the mechanism controlling, and the impact of genetics on, this adaptive response is 
not clear.  We fed 11 genetically diverse inbred mouse lines a normal (0.5%) or low 
(0.25%) Ca diet from 4-12 wks of age (n=8 per diet per line) and studied the independent 
and interacting effects of diet and genetics on Ca and bone metabolism.  Significant 
genetic variation was observed in all bone, renal, and intestinal phenotypes measured 
including Ca absorption.  Also, adaptation of Ca absorption and bone parameters to low 
dietary Ca was significantly different among the lines.  Ca absorption was positively 
correlated to femur BMD (r=0.17, p=0.02), and distal femur BV/TV (r=0.34, p<0.0001).  
While Ca absorption was correlated to 1,25 dihydroxyvitamin D (1,25(OH)2D) (r=0.35, 
P<0.0001), the adaptation of Ca absorption to low Ca intake did not correlate to diet-
induced adaptation of 1,25(OH)2D across the 11 lines. Several intestinal proteins have 
been proposed to mediate Ca absorption; claudins 2 and 12, voltage gated Ca channel 
v1.3 (Cav1.3), plasma membrane Ca ATPase 1b (PMCA1b), transient receptor potential 
vanilloid member 6 (TRPV6) and calbindin D9k (CaBPD9k).  Only the mRNA levels for 
TRPV6, CaBPD9k, and PMCA1b were related to Ca absorption (r= 0.42, 0.43, and 0.21, 
respectively).  However, a significant amount of the variation in Ca absorption is not 
explained by the current model and suggests that novel mechanisms remain to be 
determined. These observations lay the groundwork for discovery-focused initiatives to 






Whole body calcium (Ca) homeostasis is maintained by the coordination of a 
three-tissue axis of intestine, kidney, and bone(1) and this coordination is crucial for 
developing peak bone mass and minimizing adult bone loss(2,3).  In humans, fractional Ca 
absorption is positively correlated to bone mass (4-6)  while low Ca absorption efficiency 
is associated with increased fracture risk (7) and can reduce the efficacy of Ca treatment in 
the prevention of osteoporosis (4).  Despite these relationships, we still lack a clear 
understanding for how Ca absorption occurs. 
Ca absorption follows both a saturable, transcellular pathway and a passive, 
paracellular pathway that is directly proportional to dietary Ca intake.(8)  Active intestinal 
Ca absorption is especially crucial to the development of optimal bone density when 
dietary Ca intake is low. During these periods, renal conversion of serum 25 
hydroxyvitamin D (25OHD) to the active hormone 1,25 dihydroxyvitamin D 
(1,25(OH)2D) is increased.  Molecular events regulated by binding of 1,25(OH)2D to the 
vitamin D receptor (VDR) subsequently increase Ca absorption efficiency as well as 
reduce urinary Ca loss.(9-11)  Deletion of intestinal VDR in mice reduces active intestinal 
Ca absorption efficiency by 70% and this is directly responsible for the hypocalcemia and 
osteomalacia seen in VDR knockout mice.(11)    
The most studied mechanism for vitamin D-regulated intestinal Ca absorption is 
the facilitated diffusion model.(8)  In this model, 1,25(OH)2D increases the expression of 
target genes whose protein products mediate Ca entry into the enterocyte through the 
apical membrane channel transient receptor potential vanilloid member 6 (TRPV6), 




the cell through the ATP dependent-plasma membrane Ca pump, PMCA1b.(8)  While 
close relationships exist between components of the facilitated diffusion model in CaCo-
2 cells(12) and C57BL/6J mice(13,14) recent studies in knockout mice indicate that the 
facilitated diffusion model may not be accurate (15). 
In human studies, the efficiency of intestinal Ca absorption varies from 7-75%.(16-
18)  The variation in intestinal Ca absorption efficiency in humans is likely due to the 
influence of multiple physiologic (e.g. growth, pregnancy, lactation, aging), 
environmental variables (e.g. dietary Ca intake, vitamin D status), and genetic factors.  
Twin studies, genetic mapping studies in mice, and GWAS in humans reveal that several 
aspects of whole-body Ca and bone homeostasis are influenced by genetics, e.g. multiple 
bone endpoints(19,20) (human findings reviewed in(21)), serum 25OHD (22). However, less 
information is available for the impact of genetics on the efficiency of Ca absorption and 
the adaptive upregulation of Ca absorption to low dietary Ca intake.  Two groups have 
reported that the efficiency of intestinal Ca absorption is higher in C3H/HeJ mice 
compared to C57BL/6J mice, suggesting genetic background may influence this trait.(23,24)  
In addition, racial differences in the ability of adolescent girls to increase Ca absorption 
efficiency during periods of low dietary Ca intake indicate that this adaptive response 
also has a genetic component.(25,26)   
To determine the genetic contribution to the efficiency of Ca absorption, we 
examined 11 inbred lines of mice fed defined diets containing either high or low Ca 
content from weaning to 12 wks of age.  Using this population, we have identified 
genetic variation in intestinal Ca absorption efficiency as well as a number of other 




effects controlling the adaptive response of Ca absorption and other parameters to low 
dietary Ca intake. Collectively, our findings suggest that Ca absorption physiology is 
more complex than suggested by the facilitated diffusion model and that novel genetic 
factors affecting Ca absorption as well as diet-induced adaptation of Ca/bone metabolism 
have yet to be identified. 
 
2.3 Materials and Methods 
 
 Experimental Design 2.3.1
Four week old, male mice from 11 common laboratory inbred strains were 
obtained from The Jackson Labs (Bar Harbor, ME): 129S1/SV1mJ (129S), A/J, AKR/J 
(AKR), C3H/HeJ (C3H), C57BL/6J (B6), CAST/EiJ (CAST), CBA/J (CBA), DBA/2J 
(DBA), PWK/PhJ (PWK), SWR/J (SWR), and WSB/EiJ (WSB).  This panel of lines was 
chosen to encompass three mouse subspecies (Mus musculus domesticus, M.m.musculus, 
and M.m. castaneus), to include classical inbred strains as well as more genetically 
divergent wild-derived inbred lines, and to represent parental strains of available genetic 
mapping resources.(27)  To minimize differences in availability and breeding efficiency 
among the lines, lines were shipped in groups of 4-8 mice within each of two shipment 
periods.  At arrival, an equal number of mice from each line were randomly assigned to 
either a 0.5% Ca (adequate) or 0.25% Ca (low) diet (AIN93G base with 200 IU vitamin 
D3/kg diet, Research Diets, New Brunswick, NJ) (n=8/diet/line). Dietary Ca levels were 
chosen to maintain Ca homeostasis (0.5% Ca) or elicit an adaptive response in serum 




lights (Pegasus Lighting, Beaver Falls, PA) and a 12 h light/dark cycle; they were given 
food and water ad libitum.  At 12 wks of age mice were fasted overnight, anesthetized 
with a cocktail of ketamine and xylazine, and Ca absorption was measured by Ca45 
appearance in the serum 10 min after an oral gavage test as previously described.(10)  
Blood was drawn and serum was prepared for the analysis of intestinal Ca absorption by 
liquid scintillation and 1,25(OH)2D levels by radioimmunoassay as previously 
described.(11,28)  Duodenum and kidney were prepared for mRNA analysis.  Data from a 
pilot study characterizing the response of B6, DBA, and PWK mice to dietary Ca 
restriction were included in the final analysis of available phenotypes (total sample size 
for these lines=16-24/diet).  All animal experiments were approved by the Purdue 
University Animal Care and Use Committee. 
 
 Intestinal Calcium Absorption 2.3.2
Anesthetized mice were given an oral gavage of a solution containing 0.1 mM 
CaCl2, 125 mM NaCl, 17 mM Tris, and 1.8 g/L fructose, enriched with 20 µCi 
45CaCl2/ml (Perkin Elmer, Waltham, MA) (15 µL/g body weight).  Ten minutes later, 200 
µL of blood was drawn from the superficial temporal vein using the Goldenrod Lancet 
(Medipoint, Inc., Mineola, NY).  Serum was isolated by centrifuging samples for 10 min. 
at 500 x g.  Each serum sample was bleached by dilution (1:10) in a 1:4 solution of 3N 
potassium hydroxide and 30% hydrogen peroxide for 30 min, after which pH was 
neutralized with 3N hydrochloric acid.  Samples were then counted by liquid scintillation 




 Gene Expression 2.3.3
Mucosal scrapings were obtained from the first 2 cm of the duodenum.  The left 
kidney was minced and approximately 50 µg saved. These samples were mixed and 
immediately frozen in TriReagent. Total mRNA was isolated and reverse transcribed into 
cDNA(28). Real-time PCR was conducted on samples using the MyiQ RT-PCR system 
containing SYBR green (Bio-Rad, Hercules, CA).  mRNA levels were normalized to the 
expression of ribosomal protein, large, P0 (RPLP0).  Primers used for qPCR have been 
described elsewhere: RPLP0(28), CaBPD9k(9), and TRPV6(9), PMCA1b(29), Cav1.3
(30), 
claudin 2 (CLDN2)(31), claudin 12 (CLDN12)(32), TRPV5(9), CaBPD28k(11).   
 
 Bone Phenotyping 2.3.4
Hindlimbs were removed, skin was removed, and the remaining tissue was fixed 
in 10% neutral buffered formalin for 2 weeks after which the tissue was stored in 70% 
ethanol.  After all muscle was removed bones were transferred back to 70% ethanol.  
Formalin-fixed femora were scanned using a PIXImus densitometer (Lunar; GE-
Healthcare, Madison, WI) to yield bone mineral content (BMC, g) and bone mineral 
density (BMD, g/cm2) or by microcomputed tomography (µCt 40, Scanco Medical, AG, 
Bassersdorf, Switzerland) at the midshaft and distal metaphysis.(33)  Samples were 
scanned for µCt while immersed in 70% ethanol.  Images were obtained using a cubic 
voxel size of 16 µm, X-ray tube potential of 55 kVp, an X ray intensity of 145 µA, and 
300 ms integration time.  
The region of interest (ROI) for cortical bone was at 50% of the length of the 




bone volume fraction (Ct.Ar/Tt.Ar, %) and cortical thickness (Ct. Th, mm) were 
calculated.  For trabecular bone, the ROI was set at 1 mm from the growth plate, 94 slices 
were scanned (1.5 mm) and 56 slices (1 mm) were reconstructed starting from the first 
slice containing no evidence of growth plate or primary spongiosa.  Reference contours to 
delineate trabecular bone region were drawn manually a few voxels away from the 
endocortical surface, the shape of the reference contours were automatically adapted to 
the bone surface approximately every 10 slices. Images were segmented using Gaussian 
filtration (Sigma = 0.8, support = 1).  Parameters calculated for trabecular bone were 
bone volume/total volume (BV/TV, %), trabecular number (Tb.N, 1/mm), trabecular 
spacing (Tb.Sp, mm), and trabecular thickness (Tb.Th, mm).  All images were 
reconstructed using the Scanco software and measures obtained were based on 3D model-
independent algorithms.  A single global threshold value was set manually for each ROI.  
The reproducibility of this method for mouse femur is reported elsewhere.(33,34) 
 
 Statistical Analysis 2.3.5
Data points with a z score in the extreme 2.5% of either end of a line/diet group 
distribution were removed as outliers.  Adherence to a normal distribution was 
determined by Anderson-Darling tests.  Data not normally distributed were transformed 
as follows: Ca absorption (log 10); VDR (y0.5); TRPV6 and 1,25(OH)2D (y
0.25); duodenal 
and renal CaBPD9k, PMCA1b, CLDN2, CLDN12, Cav1.3, Tb.Sp, Tb.Th, BV/TV, 
TRPV5, and CaBPD28k (natural log).  Adherence to a normal distribution was confirmed 
after transformation.  Each phenotype was assessed for the presence of main effects (line, 




length (FL) as body size covariates.(35)  When a significant F statistic was detected, 
specific a priori post-hoc comparisons were made using a permutation-based t-test 
procedure (Supplemental Table 2.3).  Relationships between phenotypes were determined 
after, significant, independent confounding effects of BW and/or FL were removed by 
linear regression (35).  Phenotypes affected by BW and FL were: BMD, BMC, Tb.N, 
Tb.Sp, and renal CaBPD9k; while Ca absorption, TRPV6, duodenal CaBPD9k, PMCA1b, 
VDR,  CLDN2, CLDN12, 1,25(OH)2D, Tb.Th, Ct.Th, and Ct.Ar/Tt.Ar were affected by 
BW only and BV/TV was affected by FL only.  The resulting residual values were used 
in Pearson’s correlations, full model linear regression, and principal components analysis 
(PCA).    The number of factors extracted in PCA was based on the Kaiser criterion 
(eigenvalue >1) and scree plot examination.(36)  Factors were next rotated using the 
orthogonal Varimax rotation.  Factor loadings >0.4 or <-0.4 were used for interpretation 
of each principal component. 
For several phenotypes, a unique adaptation parameter reflecting the response to 
low dietary Ca intake was generated for each mouse on the 0.25% Ca diet.  This was 
calculated as the percent difference between the phenotype value for an individual (i) fed 
the 0.25% Ca diet (x) and the line (j) mean for the phenotype value from the 0.5% Ca diet 
(y), standardized to the line mean for the phenotype value from the 0.5% Ca diet and 
multiplied by 100, i.e.��𝑥𝑖𝑗 − 𝑦�𝑗�/𝑦�𝑗�*100. The adaptation parameter was normally 
distributed and not affected by body-size covariates for any phenotype.  Summary 
statistics of adaptation parameters are given in Supplemental Table 2.4.  The effect of 
genetic variation on the adaptation parameter was tested in a one-way ANOVA.  The 




using a one-sample t-test (H0=0).  All analyses were conducted using SAS Enterprise 4.2 
(SAS Institute, Inc., Cary, NC) and significance determined at p<0.05.  
Our primary research goal was to determine the effect of genetics on Ca 
absorption and so the study was powered based on variance estimates from B6 mice for 
this phenotype (n=8, 50% difference between dietary groups, SD = 30% of mean, α = 
0.05, power = 0.872).  Using this sample size we had sufficient power to detect 
significant differences in mRNA endpoints (100% difference, SD = 50%, power = 0.96) 
and distal femur µCT parameters (30% difference, SD = 20%, power = 0.797) but femur 
midshaft, BMD, and BMC had reduced power 0.461).  Our linear associations with 




 Ca Absorption and Its Adaptation to Low Dietary Ca Intake 2.4.1
Unadjusted values and least squares means from ANCOVA are provided for all 
parameters in Supplemental Tables 2.1 and 2.2, respectively.  Intestinal Ca absorption 
was significantly affected by genetic background (line) regardless of the level of dietary 
Ca fed (Figure 2.1A, p<0.0001) with CBA, A/J, and WSB lines having the highest 
absorption efficiency on the 0.5% Ca diet and 129S, CAST, and DBA lines having the 
lowest.   
As expected, Ca absorption efficiency was significantly increased by low dietary 
Ca intake in the B6 reference line (+82%, p<0.0001).  However, the adaptation of Ca 




diet interaction, p=0.009).  Low Ca intake significantly increased Ca absorption only in 
the B6 and 129S lines (Figure 2.1A).  Consistent with this observation, analysis of the Ca 
absorption adaptation parameter shows that the B6 and 129S lines were significantly up-
regulated (p<0.05) while a trend towards increased Ca absorption was also seen for 
CAST, DBA, C3H, and SWR (p<0.1, Figure 2.1B). Lines with no diet-induced increase 
in Ca absorption were: A/J, AKR, CBA, PWK, and WSB. 
 
 Bone Parameters, and Their Adaptation to Low Dietary Ca Intake 2.4.2
BMD was affected by significant line and diet main effects, as well as a 
significant line-by-diet interaction (p=0.038).  Variability in BMD across the population 
for each diet can be seen in Figure 2.2A.  Similar levels of variation were also seen for 
Ct.Ar/Tt.Ar, distal femur BV/TV, Tb.Th, Tb.N, and Tb.Sp (Supplemental Table 2.3).  
However, the impact of line on bone loss due to dietary Ca restriction was different 
among BMD, Ct.Ar/Tt.Ar, and BV/TV (line effect p=0.005, p=0.8, p<0.0001, 
respectively; Figure 2.2B-D).  Only PWK mice were resistant to diet-induced bone loss 
in all three measures.  The adaptive response of distal femur BV/TV to low Ca diets was 
most heterogeneous with significant loss of  BV/TV observed in 129S, AKR, and DBA 
lines, no change in A/J, C3H, CAST, CBA, PWK, and WSB lines, and an increase in B6 
(p=0.04) and SWR lines (p=0.1) (Figure 2.2D). 
 
 Ca Absorption Efficiency Is Correlated to Bone Mass 2.4.3
Ca absorption was positively correlated to BMD (r=0.17, p=0.02, Table 1).  This 




Figure 2.3, Tb.Th, Table 1).  In contrast, while Ct.Ar/Tt.Ar correlated to Ca absorption in 
mice on the 0.5% Ca diet (r = 0.25, p for trend = 0.052), the relationship was not 
significant for mice fed the 0.25% Ca diet or for the combined population. 
 
 Regulation of Intestinal Ca Absorption by 1,25(OH)2D 2.4.4
Using in situ ligated loops, we previously showed that Ca absorption efficiency is 
significantly correlated to serum 1,25(OH)2D in B6 mice (r
 = 0.92(14)).  We confirmed 
this relationship in B6 mice using the oral gavage test (r=0.65, p=0.0006) (Figure 2.4, 
black symbols).  In the full panel of 11 inbred lines the relationship was still significant, 
but weakened (r=0.35, p<0.0001, Figures 2.4 and 2.5) due to the high degree of diversity 
in the relationship between adaptation of Ca absorption and adaptation of serum 
1,25(OH)2D to low Ca intake among the lines.  Figure 2.6 shows that only two lines had a 
proportional, diet-induced increase in Ca absorption and serum 1,25(OH)2D (B6, C3H).  
In contrast, other lines were hyper-responders (i.e. the diet-induced increase in Ca 
absorption was high relative to the diet-induced increase in serum 1,25(OH)2D in 129S 
and CAST), or hypo-responders (i.e. a blunted response in Ca absorption in relation to a 
large increase in serum 1,25(OH)2D in PWK and SWR).  Two other lines increased Ca 
absorption with little to no corresponding increase in serum 1,25(OH)2D (i.e. vitamin D-
independent in WSB, DBA), while three lines did not increase either Ca absorption or 
serum 1,25(OH)2D on a low Ca diet (i.e. non-responders were CBA, A/J, AKR) (Figure 





 Correlations between Duodenal mRNA Levels and Ca Absorption 2.4.5
Several proteins have been proposed to contribute to basal and vitamin D-
regulated intestinal Ca absorption, i.e. VDR, TRPV6, CaBPD9k, PMCA1b, CLDN2, 
CLDN12, and Cav1.3.(8)  Line effects influenced the duodenal mRNA level for each of 
these genes (Supplemental Table 2.3).  However, only TRPV6 and CaBPD9k mRNA 
levels were significantly increased by dietary Ca restriction.  Consistent with their 
proposed roles in the facilitated diffusion model(8), TRPV6, CaBPD9k, and PMCA1b 
mRNA were each significantly, positively correlated with Ca absorption efficiency 
(Figure 2.7A-C).  Additionally, each gene target was positively correlated to serum 
1,25(OH)2D (Table 2) and the three mRNA levels were closely correlated with one 
another (Table 2, Figure 2.8).  When all three mRNAs were included in a multiple linear 
regression model for Ca absorption, only CaBPD9k mRNA level remained significant, 
indicating that these three factors are not independent determinants of Ca absorption. 
Duodenal CLDN2, CLDN12, and Cav1.3 mRNA levels were not significantly correlated 
to Ca absorption or to serum 1,25(OH)2 D levels (data not shown). Although VDR 
mRNA correlated with TRPV6, CaBPD9k, and PMCA1b mRNA, it did not correlate 
with Ca absorption (Table 2).  Diet-induced changes in CaBPD9k mRNA, but not the 
other mRNAs, were correlated to the adaptation of Ca absorption to low Ca intake 
(r=0.38, p<0.0001, Figure 2.9).  However, while VDR mRNA levels did not correlate to 
the adaptive increase in Ca absorption using mean values from the full panel of 11 inbred 
line (n = 11, r = 0.44, p = 0.17), a significant correlation was observed when the 





 Renal mRNA Levels 2.4.6
Renal levels of TRPV5, CaBPD28k, and CaBPD9k mRNA were significantly 
affected by genetic background (Supplemental Tables 2.1 and 2.3) while only CaBPD28k 
and CaBPD9k were significantly influenced by diet and no significant line-by-diet 
interaction was detected for any of the three renal mRNAs.  CaBPD28k and CaBPD9k 
mRNA were significantly, positively correlated with serum 1,25(OH)2D (r = 0.27 and 
0.33, respectively, p<0.001) but TRPV5 mRNA was not (Supplemental Table 2.5).  
TRPV5 mRNA was negatively correlated with intestinal Ca absorption (r = -0.23, 
p=0.007) while TRPV5, CaBPD28k, CaBPD9k mRNA levels were negatively correlated 
with several bone parameters (e.g. r =  -0.25, -0.43, -0.33 with Ct.Th., respectively, p < 
0.002, Supplemental Table 2.5).   
 
 Principal Components Analysis (PCA) 2.4.7
Two significant principal components (PC1, PC2) were extracted and they 
account for 30.8% and 25.9% of the total variance, respectively (Supplemental Table 2.6).  
PC1 contained intestinal Ca absorption, duodenal mRNA levels, and renal CaBPD9k 
mRNA.  PC2 contained factors from each arm of the 3-tissue axis; Ct.Ar/Tt.Ar, BV/TV, 
Ca absorption, and renal mRNA levels. 
 
2.5 Discussion 
Identification of genetic diversity in inbred mouse lines has been the foundation 
for quantitative trait loci (QTL) mapping, candidate gene, and genome wide association 




studies have examined the effects of genetics on tissues controlling Ca metabolism other 
than bone, nor have interactions between genetics and diet been accounted for, resulting 
in inconsistencies in the association between dietary Ca intake and bone health.(37-41)  Our 
study addresses this knowledge gap with a special focus on intestinal Ca absorption.  We 
demonstrate that although feeding Ca restricted diets to growing mice initiates a 
physiological adaptation to protect bone, the robustness of this adaptive response is 
dependent on genetic background (Figure 2.1 and 2.2, Supplemental Table 2.4).  For 
most of the phenotypes we examined, there was no correlation between the basal genetic 
effect and adaptation of a phenotype to low Ca intake, demonstrating that these genetic 
effects are distinct. 
Bone is the most abundant store of Ca in the body and is influenced by regulatory 
mechanisms occurring at the bone, intestine, and kidney.  Our data show that while 
significant gene-by-diet interactions control the adaptation of bone mass and intestinal Ca 
absorption to low dietary Ca intake, no interaction influenced the renal levels of 
transcripts related to Ca reabsorption. This suggests that while genetic variation affecting 
renal Ca handling may contribute to bone health, it may be less critical for the adaptive 
response to Ca restriction in growing mice.  We expected that renal TRPV5, CaBPD28k, 
and CaBPD9k levels, as surrogate markers of renal Ca reabsorption, would be tightly 
correlated to each other and positively associated with both serum 1,25(OH)2D and bone 
parameters (i.e. improved Ca retention = improved bone).(9,42)  However, while CaBPD9k 
and D28k mRNA levels were positively associated with serum 1,25(OH)2D levels (r = 
0.33, 0.27, respectively, p<0.001), TRPV5 mRNA was not.  The lack of correlation 




modest changes in renal TRPV5 mRNA levels between wild-type and VDR knockout 
mice(10,13)  and following injection with pharmacologic levels of 1,25(OH)2D
(9).  Previous 
studies report that urinary Ca excretion is higher in mice with TRPV5 gene deletion or 
low renal CaBPD9k and D28k levels(42,43) suggesting a positive role for these proteins in 
limiting bone loss and maintaining bone density.  In contrast, we found that the three 
renal mRNA levels were individually, and in a principal components analysis, negatively 
associated with various bone endpoints. We hypothesize that this is an indirect effect that 
reflects a reduced need for renal Ca reabsorption when intestinal Ca absorption is high.  
This idea is supported in part by a negative association between renal TRPV5 mRNA and 
Ca absorption. 
The primary goals for our study were to evaluate the genetic influences on 
intestinal Ca absorption as well as to use our genetically diverse population to learn more 
about mechanisms for Ca absorption and the contribution of Ca absorption to 
development of peak bone mass.  Two previous studies showed that Ca absorption was 
greater in 8-12 week old female C3H than B6 mice fed a Ca-sufficient diet (0.4% or 1.2% 
Ca).(23,24)  We have extended these observations to 11 inbred strains and our data reveal a 
large amount of variation in Ca absorption efficiency in mice fed an adequate or low Ca 
diet, as well as in the ability of mice to adapt to low dietary Ca intake (Figure 2.1).   
Armbrecht et al.(24) previously showed that the maximal response of Ca 
absorption to 1,25(OH)2D injection was not different between C3H and B6 mice.  In 
contrast, our study examined a nutritionally and physiologically relevant condition – 
restriction of dietary Ca by 50%, i.e. similar to the relationship between Ca intake and Ca 




follow the traditional model of adaptation to low dietary Ca intake(9); increases in serum 
1,25(OH)2D induce active intestinal Ca absorption that protect mice from bone loss 
through a VDR dependent mechanism(8,9,13).  However, while we see variation in the Ca 
absorption response to low dietary Ca intake across the 11 lines, this variation was not 
strongly associated with diet-induced increases in serum 1,25(OH)2D levels (Figure 2.6).  
Subpopulations were identified in the panel of 11 lines that reflected “normal” and 
“hyper” adapters, vitamin D-independent adapters, vitamin D-resistant adapters, and non-
adapters. The lack of a strong relationship between adaptation of Ca absorption and diet-
induced changes in serum 1,25(OH)2D were not due to obvious line-specific differences 
in duodenal VDR mRNA level (Supplemental Tables 2.2 and 2.4).  We previously 
reported that growth hormone or IGF-1 contributes to the residual Ca absorption 
efficiency that exists in growing VDR knockout mice.(13)  However, we measured Ca 
absorption in mice that were past their rapid growth phase and our data was adjusted for 
body size to minimize growth-related effects on our phenotypes.  Taken together, these 
observations indicate the existence of a vitamin D-independent, enhancing effect of low 
Ca intake on Ca absorption but the mechanism for this is not clear.   
In B6 mice there is a close relationship between serum 1,25(OH)2D levels and Ca 
absorption efficiency (Figure 2.3, r = 0.65; r = 0.9(14)).  However, when the genetic 
diversity available in our 11 line panel is considered, the relationship of Ca absorption to 
serum 1,25(OH)2D is more similar to that reported in humans (r = 0.23-0.35)
(45-47)(Figure 
2.4). Known environmental factors such as diet, age, and circulating hormones account 
for, at most, one quarter of the variation in true fractional Ca absorption seen in human 




due to genetic factors and gene-by-diet interactions.  Consistent with this concept, 
adolescent black girls have higher Ca absorption compared to white girls(49) and this may 
contribute to the higher bone deposition seen in black girls(50).  Also, serum 1,25(OH)2D 
is a significant predictor of Ca absorption in black but not white women, suggesting an 
impact of genetics on this relationship.(16)  Here we found that adaptive increases in Ca 
absorption were not strongly correlated to diet-induced changes in serum 1,25(OH)2D.  
This suggests that resistance or hyper-responsiveness to the action of 1,25(OH)2D may 
reflect defects in the VDR-dependent regulatory system.(12,14)  However, there were also 
no obvious polymorphisms in the VDR gene that segregate with the responses of the 
mouse lines studied here.  Identification of the genetic factors controlling Ca absorption 
has been difficult because studies on polymorphisms in candidate genes have been 
limited and inconsistent.(8)  In addition, the environmental and genetic complexity of free-
living human populations makes identifying gene-by-diet interactions difficult, especially 
for a hard to measure physiologic trait like Ca absorption.  In contrast, our study in 
genetically well-characterized mouse models raised in a controlled environment provides 
a strong foundation for future gene mapping studies to identify the genetic variants that 
control intestinal Ca absorption efficiency as well as its adaptation to low dietary Ca 
intake.(27)   
Our study has also allowed us to examine three models proposed to describe 
intestinal Ca absorption(8), i.e. the facilitated diffusion model, passive diffusion through 
the tight junction proteins CLDN2 and CLDN12 (51), and transcellular Ca transport 
through the voltage gated Ca channel Cav1.3 
(52).  Although CLDN2, CLDN12, and 




affected by line, none of them were influenced by diet nor were they significantly 
associated with Ca absorption or serum 1,25(OH)2D.  This observation indicates they 
play a minimal role in Ca absorption under our experimental conditions (i.e. a low Ca 
load in our absorption test designed to reveal transcellular, not paracellular, Ca transport).   
In the facilitated diffusion model(53), TRPV6, CaBPD9k, and PMCA1b work in 
coordination to mediate Ca absorption, e.g. in B6 mice, TRPV6 and CaBPD9k levels are 
elevated by increased serum 1,25(OH)2D levels and they are associated with increased Ca 
absorption efficiency(9).  However, the role of these proteins in Ca absorption has been 
questioned due to lack of a dramatic phenotype in TRPV6 and CaBPD9k knockout 
mice.(15)  Our data indicate that TRPV6, CaBPD9k, and PMCA1b likely perform as a 
single functional unit; multiple linear regression and PCA indicated that TRPV6, 
CaBPD9k, and PMCA1b mRNA were not independent predictors of Ca absorption.   
However, the correlations of these messages with Ca absorption, while significant, are 
weak (r values < 0.43 lead to r2 < 0.18 or less), indicating that only a small portion of the 
variability in Ca absorption is dependent upon the facilitated diffusion model (Table 2.2).  
In addition, only the adaptation of CaBPD9k mRNA to low Ca intake was significantly 
correlated to low dietary Ca-induced adaptation of Ca absorption. This observation 
supports our hypothesis that CaBPD9k expression is a response to the elevated 
intracellular Ca levels that accompany Ca absorption, but it does not strongly support an 
exclusive role for the facilitated diffusion model as the mediator of Ca absorption.(28)  
In conclusion, we have shown that genetic variation and gene-by-diet interactions 
affect not only active intestinal Ca absorption, but also its relationship to bone.  These 




(i.e. TRPV6, CaBPD9k, PMCA1b mRNA) and the hormonal regulator (i.e. 1,25(OH)2D) 
of Ca absorption.  However, the characterization done here, on 11 inbred lines of mice in 
a carefully controlled environment, indicates that there are aspects of Ca homeostasis that 
remain to be discovered.  Future studies using mouse genetic mapping populations, such 
as recombinant inbred line panels, are needed to map genetic loci responsible for our 
observation.(27)  Further characterization of the gene-by-diet interactions identified here 
will provide insight into their impact on fracture risk and will provide scientific support 
for defining dietary requirements for individuals or genetically distinct subgroups. 
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Table 2.1  Correlation of Bone Density and Morphometry Parameters to Ca Absorption 
Phenotype r (95% CL) p n 
BMD 0.172 (0.025-0.312)  p=0.02 n=176 
BMC 0.048 (-0.104-0.198)  p=0.54 n=168 
Ct.Ar/Tt.Ar  0.085 (-0.086-0.251) p=0.33 n=134 
Ct.Th 0.102 (-0.066-0.265) p=0.24 n=138 
BV/TV  0.338 (0.178-0.481) p<0.0001 n=133 
Tb.Th 0.277 (0.134-0.438) p=0.0004 n=140 
Tb.Sp -0.106 (-0.269-0.063)  p=0.22 n=137 
Tb.N 0.055 (-0.115-0.221)  p=0.53 n=135 
Pearson’s correlation coefficients are given: r (upper, lower 
95% confidence limits).  Body size corrected residuals were 





Table 2.2 Pearson's Correlation Coefficients of Ca Absorption Regulators 
 Ca Absorption TRPV6 CaBPD9k PMCA1b 1,25(OH)2D 
TRPV6 
0.42 (0.26, 0.55) 
p<0.0001, n=127 
    
CaBPD9k 
0.43 (0.27, 0.55) 
p<0.0001, n=153 
0.74 (0.65, 0.80) 
p<0.0001, n=140 
   
PMCA1b 
0.21 (0.04, 0.37) 
p=0.02, n=129 
0.53, (0.40, 0.64) 
p<0.0001, n=142 




0.35 (0.21, 0.48) 
p<0.0001, n=166 
0.44, (0.30, 0.57) 
p<0.0001, n=139 
0.39, (0.27, 0.51) 
p<0.0001, n=189 




-0.02 (-0.19, 0.15) 
p=0.82, n=132  
0.45, (0.31, 0.54) 
p<0.0001, n=147 
0.23, (0.06, 0.37) 
p=0.01, n=145 
0.53, (0.40, 0.63) 
p<0.0001, n=148 
0.09, (-0.07, 0.25) 
p=0.29, n=146 
Pearson’s correlation coefficients are given: r (upper, lower 95% confidence limits), p-value, n.  Body size 










Figure 2.1  Ca absorption and adaptation of Ca absorption to low Ca intake is variable 
among 11 inbred mouse lines.  Bars reflect the mean ±SEM (n=4-14 per diet for each 
line).  (A) Unadjusted Ca absorption values, * dietary groups within a line differ 
significantly (p<0.05); line mean differs significantly relative to the B6 reference line 
(p<0.05), † for the 0.5% Ca group, ^ for the 0.25% Ca group. (B) Adaptation of Ca 







Figure 2.2  Bone parameters and adaptation of bone parameters to low Ca diets are 
variable among 11 inbred mouse lines.  Bars reflect the mean ±SEM (n=7-20 per diet for 
each line). (A) Unadjusted BMD values, * dietary groups within a line differ significantly 
(p<0.05); line mean differs significantly relative to the B6 reference line (p<0.05), † for 
the 0.5% Ca group, ^ for the 0.25% Ca group. (B-D) Adaptation to low dietary Ca intake 
for (B) BMD, (C) BV/TV, and (D) Ct.Ar/Tt.Ar; adaptation significantly differs from 0  







Figure 2.3  Distal femur BV/TV is significantly, positively correlated with intestinal Ca 
absorption.  Pearson’s correlation was calculated using individual residual values from 
mice representing all 11 inbred lines from both diet groups with data points present for 








Figure 2.5  Genetic diversity affects the relationship between 1,25(OH)2D and Ca 
absorption.  . The relationship between serum 1,25(OH)2D and intestinal Ca absorption 
across the 11 inbred lines (r=0.35, p<0.001, n=166, dotted line = 95% confidence 
interval) is weaker than that observed for the B6 line alone (r=0.65, p<0.01, n=24).  
0.25% Ca diet (circles), 0.5% Ca diet (squares). Body-size corrected residuals are plotted. 
Figure 2.4  Relationship between serum 1,25(OH)2D and intestinal Ca absorption across 
the 11 inbred lines (r=0.35, p<0.001, all symbols).  Values for the B6 reference line alone 
are shown as filled symbols (r=0.65, p<0.01).  0.25% Ca diet (circles), 0.5% Ca diet 









Figure 2.6  Correlation between adaptation of serum 1,25(OH)2D and intestinal Ca 
absorption to low Ca diets in the 11 inbred lines.  An adaptation parameter was calculated 





Figure 2.7  Correlation between mRNA levels for the key members in the facilitated 
diffusion model and Ca absorption.  (A) TRPV6 mRNA (r=0.42, p<0.001, n=127), (B) 
CaBPD9k mRNA (r=0.43, p<0.001, n=153), and (C) PMCA1b mRNA (r=0.21, p<0.05, 







Figure 2.8  Key members in the facilitated diffusion model are significantly interrelated 
at the mRNA level.  (A) TRPV6 to CaBPD9k (r=0.74, p<0.0001, n=140), (B) TRPV6 to 
PMCA1b (r=0.53, p<0.0001, n=142), and (C) CaBPD9k to PMCA1b (r=0.47, p<0.0001, 






Figure 2.9  Adaptation of CaBPD9k to a low Ca diet is significantly, positively 
correlated with adaptation of Ca absorption to a low Ca diet.  An adaptation parameter 
was calculated for each mouse on the 0.25% diet.  Pearson’s correlation was calculated 
using individual values from mice representing all 11 inbred lines with data points 
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Vitamin D regulates calcium (Ca) homeostasis and is necessary for proper bone 
health. Low dietary Ca intake increases the renal conversion of 25 hydroxyvitamin D 
(25(OH)D) to the hormone 1,25 dihydroxyvitamin D (1,25(OH)2D), a regulator of gene 
expression through the nuclear vitamin D receptor (VDR).   While studies have identified 
genetic variation controlling serum 25(OH)D levels, it is unclear whether genetics control 
serum 1,25(OH)2D levels or their adaptation to low Ca diets. To test this, male mice from 
11 inbred lines (Study 1) and 51 BXD recombinant inbred lines (Study 2) were placed on 
controlled diets containing 200 IU vitamin D and either 0.5% (the rodent Ca requirement) 
or 0.25% Ca from 4-12 wks of age (n=8/line/diet).  Significant variation was identified in 
Study 1 in serum 25(OH)D, serum 1,25(OH)2D, renal hydroxylases controlling vitamin D 
metabolism, and adaptation of 1,25(OH)2D to low dietary Ca. In Study 2, narrow sense 
heritability (h2) of 25(OH)D and 1,25(OH)2D on the 0.5% Ca diet was 0.40 and 0.66 , 
respectively.  The adaptive response of 1,25(OH)2D to the low Ca dietary environment 
ranged from -6% to 297% across BXD lines (h2=0.59).  Quantitative trait loci associated 
with serum 1,25(OH)2D did not overlap those linked to diet-induced adaptation, 
indicating the genes controlling the physiologic response to low dietary Ca are distinct 
from those controlling baseline levels.  Our results indicate serum vitamin D metabolite 







Vitamin D deficiency is characterized by rickets and osteomalacia, highlighting 
its important role in calcium (Ca) and bone homeostasis.(1)  Additionally, vitamin D has 
been proposed to have unique, beneficial effects in several other diseases including 
cancer, heart disease, and autoimmune disease.(1)  The regulation of vitamin D synthesis, 
metabolism, and action are complex processes.  Vitamin D is acquired from the diet or by 
de novo synthesis in the skin, after which it is hydroxylated in the liver to 25-
hydroxyvitamin D (25(OH)D) and released into the serum.  Circulating 25(OH)D levels 
are used to assess vitamin D status.  25(OH)D is the biologically inactive precursor to the 
hormonal metabolite, 1,25 dihydroxyvitamin D (1,25(OH)2D).  1,25(OH)2D functions 
through the vitamin D receptor (VDR) to maintain serum Ca homeostasis by regulating 
gene expression in the intestine, kidney and bone.(2)  This method of regulation is 
sensitive to the dietary Ca environment.  Habitually low dietary Ca intake stimulates an 
adaptive increase in the conversion of 25OHD to 1,25(OH)2D in the kidney by the 
enzyme CYP27b1.(2-4)  
Serum vitamin D metabolite levels are influenced by genetic and environmental 
factors.(5,6)  The heritability of serum 25(OH)D in human populations ranges from 23-
80%.(6-11)  However, only a few genetic factors accounting for a small amount of variance 
(1-14%) in serum 25(OH)D levels have been identified.(5,12)  Combined, environmental 
factors and selected genotypes have explained just 54% of total variance in serum 
25(OH)D levels.(12)  Together, these data suggest novel genetic factors influencing 




Heritability of 1,25(OH)2D has been estimated at 16-48% in human 
populations.(13,14)  Studies examining the effect of genetic modifiers on serum 
1,25(OH)2D level are limited.  What data are available are inconclusive because this 
metabolite is particularly sensitive to environmental (e.g. dietary Ca) and physiological 
cues (e.g. low serum Ca).  Research suggests that natural genetic variation can interact 
with the dietary Ca environment to influence 1,25(OH)2D-mediated Ca homeostasis.
(15-17) 
However, gene-by-diet interactions affecting serum 1,25(OH)2D levels have not been 
carefully studied.  Understanding the influence of natural genetic variation, the dietary 
environment, and their interaction on serum 1,25(OH)2D may elucidate new biology in 
the vitamin D metabolic pathway.  In turn, this knowledge may clarify the hormone’s 
roles in other systems. 
We have characterized the natural genetic variation in serum 25(OH)D and 
1,25(OH)2D present in a diverse population of inbred mice.  Using animal models 
allowed us to control genetic background as well as environmental conditions, thus 
overcoming the highly variable nature of 1,25(OH)2D present in free-living populations.  
Additionally, we have used a physiologically relevant habitual dietary Ca restriction in 
order to study the effect of natural genetic variation on the adaptation of serum 
1,25(OH)2D to this stress and have conducted quantitative trait locus (QTL) mapping to 
identify genetic regions controlling serum vitamin D metabolite levels and the adaptation 
of 1,25(OH)2D to low Ca intake.  This is the first linkage mapping study to identify loci 






3.3 Materials and Methods 
 
 Animal Models 3.3.1
Study 1 was a characterization of serum vitamin D metabolites in a diverse 
population of 11 inbred mouse lines; 129S1/SV1mJ (129S), A/J, AKR/J (AKR), 
C3H/HeJ (C3H), C57BL/6J (B6), CAST/EiJ (CAST), CBA/J (CBA), DBA/2J (DBA), 
PWK/PhJ (PWK), SWR/J (SWR), and WSB/EiJ (WSB).  Intestinal Ca absorption and 
bone related phenotypes for this population have been reported previously.(18)  Study 2 
was a forward genetic linkage mapping study to identify QTL influencing serum vitamin 
D metabolites using the BXD recombinant inbred (RI) panel.  In the BXD RI panel, each 
line is a unique recombination of the B6 and DBA parental genomes, but because each 
BXD line is inbred, each individual within a line is genetically identical.(19)  This aspect 
allows for biological replicates to test an environmental intervention such as diet.(19) 
 
 Experimental Design 3.3.2
Using the study design reported previously(18), male mice from the 11 inbred lines 
(Study 1) and 51 BXD RI lines (Study 2) were obtained at 4 wks of age (The Jackson 
Labs, Bar Harbor, ME).  At arrival, an equal number of mice from each line were 
randomly assigned to either a 0.5% Ca (adequate) or 0.25% Ca (low) diet (AIN93G base 
with 200 IU vitamin D3/kg diet, Research Diets, New Brunswick, NJ) (n=8/diet/line).  
Dietary Ca levels were chosen to meet the rodent dietary Ca requirement (0.5% Ca) or 
elicit an adaptive response to low Ca intake in serum 1,25(OH)2D (0.25% Ca).  Mice 




water ad libitum.  At 12 wks of age mice were anesthetized with an intraperitoneal 
injection of ketamine and xylazine.  Mice were euthanized by exsanguination and the left 
kidney was removed.  Serum was separated by centrifugation at 700 rcf for 10 min at 
room temperature.  Serum vitamin D metabolites 25(OH)D and 1,25(OH)2D were 
measured using commercially available radioimmunoassays (IDS, Plc., Scottsdale, AZ) 
according to the manufacturer’s directions.  Renal tissue was harvested and mRNA 
isolated as described previously.(18)  Renal CYP24 and CYP27b1 mRNA was measured 
by real-time PCR as previously described.(20)  All animal experiments were approved by 
the Purdue University Animal Care and Use Committee. 
 
 Statistical Analysis 3.3.3
Statistical methods for Study 1 can be found in Replogle et al.(18)  Study 1 was 
transformed as follows; 1,25(OH)2D (y
0.25), CYP24 and CYP27b1 (natural log) and 
adherence to a normal distribution confirmed using the Anderson-Darling test for 
normality following transformation.  ANCOVA was used in Study 1 to test for the main 
effects of genetic background (i.e. line) and diet as well as a line-by-diet interaction while 
controlling for the effect of body weight (BW) and femur length (FL) as covariates.  
Select, a priori post-hoc comparisons were made using Fisher’s LSD. Relationships 
between phenotypes were done with Pearson’s correlation tests using covariate corrected 
residuals.  25(OH)D, 1,25(OH)2D, and CYP27b1 were corrected for BW while CYP24 
was corrected for FL using simple linear regression as described elsewhere.(18) In Study 2 
the covariate effect of BW was removed by linear regression and residuals were used for 




ANOVA (main effect=line) for each diet/phenotype population.  An additional parameter 
reflecting adaptation of 1,25(OH)2D  to the low Ca diet was calculated as the percent 
difference between the raw phenotype value for an individual (i) fed the 0.25% Ca diet (x) 
and the raw line (j) mean for the phenotype value from the 0.5% Ca diet (y), standardized 
to the line mean for the phenotype value from the 0.5% Ca diet, i.e.��𝑥𝑖𝑗 − 𝑦�𝑗�/𝑦�𝑗�*100.  
Statistics were conducted using SAS Enterprise Guide 4.2 (SAS Institute Inc., Cary, NC). 
 
 QTL Mapping 3.3.4
Marker information and BXD genotypes were downloaded from GeneNetwork 
(http://www.genenetwork.org/genotypes/BXD.geno) and the genetic location of each 
marker was updated using the Mouse Map Converter tool at the Jackson Labs Center for 
Genome Dynamics (http://cgd.jax.org/mousemapconverter/).(22)  Markers with duplicate 
genetic locations or perfectly correlated genotypes in our panel of BXD lines were 
removed.  The final genetic map for the 51 lines contained 1558 markers (the list is 
available on request). 
Composite interval mapping (CIM) was conducted using Windows QTL 
Cartographer v2.5_011 (http://statgen.ncsu.edu/qtlcart/WQTLCart.htm) with RI line 
means (n=51).  Forward selection identified 5 significant background markers.  CIM was 
carried out using a Haldane map function, 2 cM walking speed, and a 10 cM window.  
Each diet (0.5% or 0.25% Ca) group and the adaptation to low dietary Ca (1,25(OH)2D 
only) were mapped separately.  Permutations (n=500) were used to determine 
significance for each analysis.(23)  A Bayesian QTL mapping method using individual 




Zhang et al., accurately detects multiple QTL in a study with a large number of marker 
effects (p) and small sample size (n).(24)  Bayes factors were used as a measure of 
significance for the presence of a QTL.  Specifically, twice the natural log of the Bayes 
factor (2lnBF) was used as a test statistic because it scales similarly to an LOD score.(25,26) 
The strength of the 2lnBF test statistic was assessed according to the rubric defined by 
Kass and Raftery; “0-2 not worth a bare mention, 2-6 positive, 6-10 strong, >10 very 
strong”.(25)  Each diet population was mapped separately as well as included together in a 
full model to test the genetic main effect.  The use of these two QTL mapping methods 
allowed us to test for QTLs within the traditional framework, but still leverage our study 
design which contained biological replicates.  Results that were replicated among the 
analyses lent more confidence to the outcome and were prioritized for further study. 
 
 Bioinformatic Characterization 3.3.5
The QTL candidate region was defined using 1-LOD support intervals which 
approximate 95% confidence intervals.(27,28)  QTL candidate regions were populated with 
genome features including protein-coding genes, non-coding RNA genes, gene fragments, 
and unclassified genes from the Mouse Genome Informatics (MGI) database 
(http://www.informatics.jax.org/).(29) Genome-wide DNase1 hypersensitive site (HSS) 
data from the mouse ENCODE project was used to identify potential regulatory regions 
(i.e. open chromatin) within QTL regions.(30)  DNase1 HSS peaks in 10 adult tissues (fat 
pad, genital fat pad, heart, kidney, large intestine, liver, lung, skeletal muscle, spleen, and 




Gene locations were identified as the region from the first to last exon plus 5000 
bp region upstream of the gene coordinates for exon 1 (i.e. the proximal promoter region).  
Genomic regions that were identical by decent (IBD) between B6 and DBA were 
identified using the Mouse Phylogeny Viewer (http://msub.csbio.unc.edu/).(31)  Regions 
that were 100% IBD were eliminated from further consideration.  Genes that were less 
than 100% IBD and the remaining non-IBD regions were used to query for 
polymorphisms between B6 and DBA using the Mouse Phenome Database (MPD, 
http://phenome.jax.org/).  MPD annotations were used to categorize polymorphisms by 
gene attribute; intronic, mRNA un-translated region (5’ and 3’ UTR), promoter region 
(5000 bp upstream), and exon-associated (i.e. synonymous and non-synonymous codons, 
stop codons, splice sites, or frameshift mutations). HSS data was then overlaid with the 
polymorphisms present in the QTL region.  Reference amino acids and variants resulting 
from non-synonymous polymorphisms were categorized based on charge, polarity, size, 
and special cases using the classification set out by Zhang et al with modifications.(32)  
Amino acids were classified into only two categories for size: small; C, P, G, A, S, T, N, 
D, Q, E, I, L, M, and V; and large; R, H, K, F, W, and Y.  Three special cases are 
considered; C, P, and G.  An amino acid substitution was considered deleterious if the 







 Variation Related to Vitamin D Metabolites and Metabolic Enzymes Was Seen 3.4.1
across the Diverse 11 Inbred Line Population 
Serum 25(OH)D was significantly affected by genetic background in the 11 
inbred line population (line effect p<0.0001, Figure 3.1A) but there was no diet effect nor 
line-by-diet interaction observed.  Significant line and diet main effects were found for 
serum 1,25(OH)2D (p<0.0001, Figure 3.1B) while a trend for a gene-by-diet interaction 
was found (p=0.09).  A significant line effect influenced the diet-mediated change in 
serum 1,25(OH)2D (p<0.0001, Figure 3.1C).  However, the adaptive increase in serum 
1,25(OH)2D was significant for only five lines; B6, 129S, PWK, and SWR (p<0.05), 
C3H (p<0.1).  CYP27b1 mRNA levels in the kidney were significantly affected by the 
main effects of line (p<0.0001) and diet (p=0.0005), but no line-by-diet interaction was 
seen (p=0.4)(Figure 3.2A).  Renal CYP24 mRNA levels showed a significant influence 
of line (p<0.0001)(Figure 3.2C) while no diet effect (p=0.6) or line-by-diet interaction 
(p=0.12) was observed.  Serum 1,25(OH)2D levels did not significantly correlate to either 
renal CYP27b1 (r=0.08, p=0.3) or CYP24 (r= -0.03, p=0.7) mRNA levels (Figure 
3.2B,D). 
 
 Genetic Loci Controlling Serum 25(OH)D 3.4.2
A significant line effect influencing serum 25(OH)D was seen in the BXD RI 
panel (p<0.0001).  The main effect of diet was not significant (p=0.2), but a significant 




scores).  The narrow sense heritability (h2) of 25(OH)D was 0.40 and 0.45 in the 0.5%  
and 0.25% Ca diet groups, respectively.  When significant QTL mapping results from all 
analyses were considered together, 13 QTLs were identified (Figure 3.4A, Table 3.1).  A 
detailed summary of the test statistics for each analysis can be found in Table 3.2. 
Two 25(OH)D QTLs were selected for in-depth bioinformatics analysis: 25D2 
(chr 1, 95.4 cM) and 25D4 (chr 6, 28.2 cM).  Table 3.3 lists the characteristics of the 1-
LOD support interval for each of these QTL.  The number of genome features remaining 
after IBD filtering was 14 and 50 for 25D2 and 25D4, respectively.  Further classification 
of functional polymorphisms at each locus is given in Table 3.4. Genes contained within 
the 1-LOD support interval are listed in Table 3.5. 
 
 Genetic Loci Controlling Serum 1,25(OH)2D and Its Adaptation to Low Ca Intake 3.4.3
Serum 1,25(OH)2D was significantly affected by line and diet main effects 
(p<0.0001) as well as a line-by-diet interaction (p=0.0002) in the BXD RI panel (see Z-
scores in Figure 3.3B).  Serum 1,25(OH)2D had a narrow-sense heritability (h
2) of 0.66 
and 0.65 in the 0.5% and 0.25% Ca diet groups, respectively.  The adaptation of serum 
1,25(OH)2D to low Ca intake was significantly affected by line (p<0.0001, Figure 3.3C), 
and had a heritability of 0.59.  
Twelve QTLs for serum 1,25(OH)2D were significant in at least one mapping 
method and one population (Table 3.1, Figure 3.4B).  Two of these loci were significant 
for the adaptation of 1,25(OH)2D to a low Ca diet: 125D10 (chr 10, 61.7 cM) and 
125D16 (chr 18, 25.0 cM) (Table 3.1, Figure 3.4B, see Table 3.6 for detailed test 




based on concordance between analyses and association with the adaptation parameter: 
125D7, 125D10, 125D15, 125D16, and 125D17.  1-LOD candidate regions of these 5 
QTLs were characterized by the number of genome features remaining after IBD filtering, 
polymorphisms, and HSS characteristics (Table 3.3).  The number of genome features 
remaining in 125D7, 125D10, 125D15, 125D16, and 125D17 after IBD filtering was 9, 
11, 18, 36, and 17, respectively.  Further classification of functional polymorphisms at 
each locus is given in Table 3.4. Genes contained within the 1-LOD support interval are 
listed in Table 3.7. 
 
3.5 Discussion 
Although vitamin D has attracted attention as a novel contributor to many health 
outcomes, strong associations between vitamin D status and health outcomes are often 
difficult because of the complex milieu of factors influencing vitamin D metabolite levels 
in a free living population.  The genetic factors influencing the status marker, 25(OH)D, 
and the active hormone, 1,25(OH)2D, are poorly understood.  We have used genetically 
variable mouse models to show that serum 25(OH)D and 1,25(OH)2D levels are 
significantly affected by genetic background in a diverse population of mice.  Variation 
in serum 1,25(OH)2D was not explained by variation in the enzymes that control its 
activation and degradation, CYP24 and CYP27b1.  The heritability of 25(OH)D in 
human populations is widely variable (23-80%) due to the effects of environmental 
factors, mainly UV exposure.(6,7,13,14,33,34)  Heritability of 25(OH)D in our BXD RI panel 
fell within this range at 40-45%.  Serum 1,25(OH)2D has also been shown to be heritable 




Americans, and 30% in European populations.(13,14)  Heritability of serum 1,25(OH)2D in 
our BXD RI panel was slightly higher, 65-66%, likely due to the ability of our 
experimental model to distill the effect of genetics by tightly controlling environmental 
factors.  Additionally, our experimental model allowed us to test for a gene-by-diet 
interaction.  Individuals within each BXD RI line serve as biological replicates, allowing 
us to test how natural genetic variation affects the adaptation of 1,25(OH)2D to habitual 
low Ca intake.  We found that the low dietary Ca adaptation of 1,25(OH)2D was 
significantly affected by genetic background in both the 11 inbred mouse lines and the 
BXD RI panel (h2= 59%).  This forward genetic study represents the first characterization 
of the effect of natural genetic variation on serum 1,25(OH)2D and its adaptation to 
habitual low Ca intake under controlled conditions. 
Our data demonstrate that the genetic control of serum vitamin D metabolites is 
multi-focal and complex.  Both 25(OH)D and 1,25(OH)2D mapped to multiple, separate 
locations in the BXD RI panel (13 and 12 loci, respectively).  The majority of genetic loci 
identified are unique to each metabolite and indicate independent controls on the serum 
levels of each metabolite.  This observation is consistent with the traditional viewpoint 
that 1,25(OH)2D is highly sensitive to physiological cues and subject to multiple points of 
regulation (e.g. habitual low dietary Ca intake (35)) while 25(OH)D is not.  In addition, the 
adaptive response of 1,25(OH)2D to low Ca intake also mapped to unique loci, 
suggesting that genetic controls on the adaptive capability of an individual are 
independent of the factors controlling baseline levels. 
The loci affecting 25(OH)D in this BXD RI panel do not contain the genes whose 




gene studies, (i.e. the vitamin D binding protein (GC) and the 25-hydroxylase, CYP2R1 
(13,36)) or genome wide association studies (GWAS) (i.e. GC, 7-dehydrocholesterol 
reductase (DHCR7), acyl-Coenzyme A dehydrogenase (ACADSB), and CYP2R1.(37)  
Both DHCR7 and ACADSB are involved in cholesterol metabolism and de novo 
synthesis of vitamin D from cholesterol upon exposure to UV radiation.(37,38)  In our 
study, all vitamin D was supplied in the diet and mice were shielded from UV radiation.  
Thus, we would not expect natural genetic variation in cholesterol metabolism genes (e.g. 
DHCR7 and ACADSB) to influence serum 25(OH)D in this experiment.  In addition, the 
BXD RI panel represents just 20% of the total variation known to exist in the mouse 
genome.(39)  Thus, although the BXD lines in this study did not harbor variants similar to 
those found in published human studies, other mouse crosses might.  None-the-less, our 
linkage mapping in BXD lines has identified new loci not yet associated with vitamin D 
status by other methods.   
One example of the unique variation we identified in the BXD RI panel is the chr 
6 QTL 25D4 (chr 6, 28 cM)   After examining genes within the 25D4 candidate regions 
for Gene Ontology (GO) terms relating to kidney filtration, lipid absorption, lipid 
trafficking, vesicular transport, and vitamin metabolism, pleckstrin homology domain 
containing, family A (phosphoinositide binding specific) member 8 (PLEKHA8 or 
FAPP2, 54 Mb) was identified.  Expression of this gene is highly enriched in the intestine 
and kidney (40) and PLEKHA8 has been indicated in lipid synthesis, apical membrane 
trafficking in polarized kidney epithelial cells, and structural confirmation of apical 
tubule carriers.(41-43)  These functions may impact recycling of the apical membrane 




and internalize GC-bound vitamin D from the urine in the kidney.(44)  We hypothesize 
that variation in PLEKHA8 disturbs the proper localization and internalization of the 
ligand-bound megalin/cubilin complex, thus altering the circulating concentration of 
25(OH)D by influencing urinary 25(OH)D levels.  In the BXD panel PLEKHA8 contains 
no non-synonymous coding polymorphisms, but does contain 5 polymorphisms within 
DNase1 HSS.  This variation suggests that gene expression or regulation of PLEKHA8, 
rather than protein function, may be altered in the BXD RI panel.  Future studies are 
needed to identify whether renal PLEKHA8 mRNA or urinary 25(OH)D levels differ 
across the BXD panel. 
Few studies have examined the genetic architecture of serum 1,25(OH)2D in a 
comprehensive manner.  Engelman et al. found polymorphisms in GC to be associated 
with 1,25(OH)2D levels in Hispanic and African Americans 
(13) while Wjst et al. found no 
significant loci controlling serum 1,25(OH)2D in a linkage mapping analysis of a 
population of German families.(14).  These findings illustrate that, despite a moderate 
level of heritability, genetic determinants of 1,25(OH)2D are difficult to identify in a 
mixed, free-living population.  However, the BXD RI panel is ideal for investigating a 
physiologically complex phenotype such as serum 1,25(OH)2D.
(19)  This mouse model 
allows us to have complete lifetime control of environmental exposure, an impossible 
task in human studies.  In addition, we were able to leverage a major strength of the BXD 
RI panel, biological replicates, in order to test for gene-by-diet interactions affecting the 
adaptation of serum 1,25(OH)2D to habitual low Ca intake.
(19)  Our QTL characterization 
highlights a gene known to mediate 1,25(OH)2D metabolism, as well as identifies novel 




125D15 (chr 15, 51 cM), does not contain any obvious new candidates, but the 
VDR gene (chr 15, 97.8Mb) is located < 1Mb from the 1-LOD region.  VDR is necessary 
for mediating the negative feedback regulation of its ligand, 1,25(OH)2D.  Ligand-bound 
VDR regulates gene expression of several genes that control vitamin D metabolism (i.e. 
CYP27b1, CYP24, and PTH).(45-48)  No predicted deleterious, non-synonymous amino 
acid substitutions or other coding region polymorphisms were found in the VDR between 
B6 and DBA.  However, polymorphisms were found in potential regulatory regions 
controlling transcription of the VDR gene.  Previously, Zella et al. used osteoblasts to 
identify seven enhancer regions within and around the VDR gene (49): 5 within the VDR 
gene (S1, S2, S4, and S5 are intronic, S3 spans exon 2), 1 at the proximal promoter (PP), 
and 1 approximately 7 kb upstream of the VDR transcription start site (U1).(49)  Using 
ENCODE data, 20 DNase1 HSS regions were found within the enhancer regions 
identified by Zella et al.(49)  Ten polymorphisms were found in these HSS: 3 within the 
S1 region, 1 within the S3 region, 4 within the S5 region, 1 within the PP region, and 1 
within the U1 region.  These polymorphisms may affect VDR gene expression by altering 
binding of transcription factors to regulatory sequences within the enhancer regions.  
Previous data from our group shows that duodenal VDR mRNA level does not differ 
between B6 and DBA mice (18).  However, lack of differential duodenal VDR expression 
does not eliminate the possibility of variability of VDR gene expression in other vitamin 
D target tissues.  The global transcription factor profile, and therefore gene expression 
profile, varies by tissue.(50)  Each VDR enhancer region identified by Zella et al. in 
osteoblasts was shown to be targeted by specific transcription factors.(49)  However, our 




to be active; S3, PP, and U1 (Fleet lab, unpublished data).  Variation in the BXD RI panel 
may influence the complex and tissue specific gene expression of VDR and, downstream, 
serum 1,25(OH)2D levels. 
Other QTLs linked to serum 1,25(OH)2D in this study represent novel variation.  
For example, 125D7 (chr 9, 18 cM) was highly significant across all of our analyses.  
Within the 125D7 candidate region is the gene encoding the transcription factor E26 
avian leukemia oncogene 1 (Ets1).  Ets1 has the potential to impact the 1,25(OH)2D 
negative feedback mechanisms mediated through 1,25(OH)2D-target genes CYP24 and 
FGF23, whose protein products inactivate and inhibit synthesis of 1,25(OH)2D, 
respectively.(51-53)  Previous studies from our group and others have identified Ets1 as a 
cofactor necessary for maximal 1,25(OH)2D-induced, transcription of the CYP24 
gene.(54,55)  Additionally, conserved Ets1 binding sites in the FGF23 proximal promoter 
suggest that Ets1 may upregulate FGF23 gene expression.(56)  Thus, similar to the classic 
feedback regulation of 1,25(OH)2D, Ets1 is induced by 1,25(OH)2D at the gene 
transcription level and then acts indirectly to down-regulate 1,25(OH)2D serum levels. 
Others have shown that 1,25(OH)2D treatment increases gene expression Ets1 in rat 
osteogenic sarcoma cells.(56)  The Ets1 gene is highly polymorphic the BXD RI panel.  It 
contains 120 polymorphisms that fall within DNase1 HSS located either upstream or 
within introns.  Future studies will be necessary to determine whether these variants 
influence Ets1 gene regulation. 
125D17 (chr 18, 49 cM) was highly significant in all analyses of serum 
1,25(OH)2D concentration.  Examination of GO terms within the 125D17 candidate 




In the BXD RI panel Rab27b contains 6 intronic HSS polymorphisms and two 3’ mRNA 
untranslated region polymorphisms which may influence its regulation and gene 
expression.  Rab27b is involved in the fusion of secretory granules with the plasma 
membrane of secretory cell types.(57)  In addition it is important for apical membrane 
trafficking in polarized epithelial cells.(57)  Parathyroid hormone (PTH), a major regulator 
of 1,25(OH)2D serum levels, is released into the circulation via fusion of secretory 
granules with the apical plasma membrane of the parathyroid gland.(58)  Also, localization 
of proteins to the apical membrane of parathyroid cells is important for signal 
transduction as well as for trafficking and fusion of secretory granules.(59)  In addition, 
apical membrane trafficking is also necessary for delivery of GC-vitamin D transport 
proteins (i.e. megalin and cubilin) to the apical plasma membrane of the kidney.  
Unfortunately, expression of Rab27b in the kidney is low and it has not been evaluated in 
the parathyroid gland.  As a result, the role of Rab27b in PTH release or renal vitamin D 
metabolite handling is unknown.   
In summary, using a mouse genetics approach we have identified considerable 
genetic diversity controlling serum vitamin D metabolite levels.  Our study is the first to 
examine the genetic architecture of serum 1,25(OH)2D in a controlled, genetically diverse 
animal model.  Our data show that genetic variation controlling serum 1,25(OH)2D 
concentrations is multifocal and complex, independent from the variation controlling 
serum 25(OH)D levels, and independent from the variation controlling adaptation of 
1,25(OH)2D  to a low Ca diet.  Although we have not been able to definitively identify 
the causal variants affecting serum vitamin D metabolite levels, we have identified 




serve as a starting point to identify novel pathway members or gene functions that will 
expand our knowledge of vitamin D physiology and pave the way for personalized health 
recommendations to better manage vitamin D status. 
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Influence   
    25(OH)D     
  1 65.3 155.0 B6 
  1 95.4 190 B6 
  3 34 75.9 B6 
  6 28.2 59.1 B6 
  6 66.2 135.3 B6 
  7 28.8 51.8 B6 
  8 63.2 119.1 B6 
  10 45.1 87.1 B6 
  11 11.8 19.4 B6 
  13 14.4 36.0 B6 
  15 39.4 82.9 B6 
  17 46.1 75.3 B6 
  X 4.4 9.1 B6 
  1,25(OH)2D     
  1 16.8 38.5 B6 
  2 13.2 19.0 DBA 
  3 33.7 74.5 B6 
  7 45.6 87.4 B6 
  9 18.1 33.6 B6 
  9 55.8 103.8 DBA 
  10 4.7 12.7 B6 
  10 61.7 114.6 DBA 
  13 53.8 102.4 B6 
  15 51.3 96.0 DBA 
  18 25.0 47.2 DBA 
  18 48.8 73.4 B6 
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1 "Full" denotes the full combined diet 
population 
 2 CIM (C) results are given in LOD, significance 
determined at 3.1 LOD for adaptation, 3.8 LOD for 
all other analyses.  LOD >2 is considered putative 
3 Bayesian (B) results are given in 2lnBF, 

































with genes  
25(OH)D                 
25D2 1 188.9-190.7 3971 14 7 8 546 215 100 
25D4 6 54.6-68.5 6690 50 32 5 968 328 183 
1,25(OH)2D                 
125D7 9 32.3-34.4 18628 9 6 1 496 750 287 
125D10 10 111.7-114.9 3902 11 8 1 204 110 16 
125D15 15 95.6-97.1 4123 18 8 5 642 345 202 
125D16 18 45.2-48.9 8915 36 19 7 826 323 142 
125D17 18 69.2-73.5 9298 17 7 9 613 258 172 
1 Polymorphisms 
       2 Genome features include; protein-coding genes, non-coding RNA genes, gene fragments, and unclassified genes  










Table 3.4  Classification of Polymorphisms in Vitamin D Metabolite QTLs 



























25(OH)D                     
25D2 1 188.9-190.7 160 1056 0 15 7 1 0 3 38 
25D4 6 54.6-68.5 310 3120 0 8 5 0 0 6 36 
1,25(OH)2D                     
125D7 9 32.3-34.4 365 2508 0 10 1 0 0 4 67 
125D10 10 111.7-114.9 96 2293 0 2 1 0 0 0 27 
125D15 15 95.6-97.1 277 1616 1 8 5 0 0 6 72 
125D16 18 45.2-48.9 410 3309 0 13 7 0 0 0 20 
125D17 18 69.2-73.5 188 3849 0 6 7 1 1 10 20 
1Numbers indicate total number of polymorphisms per category in each QTL candidate region 







Table 3.5  Candidate Genes Remaining for 25(OH)D QTLs after IBD Filtering 
25D2 25D4 
n-Tn3 Gm24092 Fkbp14* Crhr2* Gm3793* Vmn1r13 Gm20158 
Kctd3*1 Cenpf* Plekha8* Gm25963 Vmn1r4 Mmrn1 9630021D06Rik# 
Kcnk2* Ptpn14* Gm15863 Inmt* Vmn1r5 A730020E08Rik* Gm25205 
2900042K21Rik# Smyd2* 2410066E13Rik* Fam188b* Vmn1r6# Ccser1* Atoh1* 
Gm3837 Prox1* 2610209C05Rik* Gm25458 Vmn1r7# B230204D01Rik# C530040J15Rik 
A430027H14Rik Gm17566* Znrf2* Aqp1 Vmn1r8 A730075L09Rik# 2610300M13Rik# 
Gm2149 Gm23153 Nod1* Ghrhr* Vmn1r9# Gm24645 Mad2l1# 
    Gm24230* 6430584L05Rik* Vmn1r10 Gm22212# Smarcad1* 
    Ggct* Adcyap1r1* Vmn1r11 9330118I20Rik Vmn1r32# 
    Gars* Nt5c3* Vmn1r12# Grid2* Fkbp9 
Genes are listed in ascending order of 5' top strand start site bp location (given by the Mouse Genome Informatics 
Database) 
1Genes containing at least one functional polymorphism are in bold  











0.5% Ca 0.25% Ca Full1 Adaptation2 
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6 8 72 10 72 
 18 25 
      
4 
18 49 6 72 6 13 9 72   
1"Full" denotes the full combined diet population 
 2 "Adaptation" denotes the calculated adaptation to a low Ca 
diet 
3 CIM results are given in LOD, significance determined at 3.1 
LOD for adaptation, 3.8 LOD for all other analyses 







Table 3.7  Candidate Genes Remaining for Five 1,25(OH)2D QTLs after IBD Filtering 
125D7 125D10 125D15 125D16 125D17 
Kcnj5* Gm20758* Dbx2 Kcnn2 Gm3734# Tcf4* 
Kcnj1* Krr1 Gm6961* A330093E20Rik* Cdo1* 6030446J10Rik* 
Fli1*1 Glipr1* A130051J06Rik* Gm26262 Atg12 Gm24845* 
Gm22060 Glipr1l1 Ano6* Trim36* Ap3s1 4732423E21Rik* 
Ets1* Glipr1l2 Gm17546* 1700018A14Rik A430019L02Rik 9630026C02Rik* 
Gm3331* Glipr1l3 Gm25070* Pggt1b* 4833403I15Rik* Gm20343* 
Gm21540* Caps2 3110045A19Rik* Gm23914 Gm23610 Gm22508* 
Gm25439 Kcnc2 D030018L15Rik Ccdc112* Arl14epl Ccdc68* 
7630403G23Rik* Trhde* 2610037D02Rik# n-Tt10 Commd10* 1700061H18Rik* 
  4930473D10Rik# 4833422M21Rik* 4930415P13Rik* Gm22791 4930448D08Rik# 
  Gm15723# E330033B04Rik# Gm4107* Hspe1-rs1* Rab27b* 
  
 
Arid2* Gm24617# Gm25036* Poli* 
  
 
Gm25397 Mospd4# Sema6a* Mbd2* 
  
 
Scaf11* Gm24076 9130209A04Rik C230075M21Rik* 
  
 
Slc38a1* Fem1c* Gm5095* Dcc* 
  
 
Gm22045* Ticam2* Gm4146* 5730478J17Rik* 
  
 
Slc38a2* Tmed7* G630055G22Rik Gm19825 
    Slc38a4* Eif1a* Gm5506#   
Genes are listed in ascending order of start site bp location (given by the Mouse Genome Informatics Database) 
1Genes containing at least one functional polymorphism are in bold  






Figure 3.1  Serum vitamin D metabolites and the low dietary Ca adaptation of 
1,25(OH)2D are variable in a genetically diverse population of 11 inbred mouse lines.  
Bars reflect the mean ±SEM (n=6-20 per diet per line).  (A) Unadjusted serum 25(OH)D 
values, *dietary groups within a line differ significantly; line mean differs significantly 
relative to the B6 reference line, † for the 0.5% Ca group, ^ for the 0.25% Ca group 
(p<0.05) (B) Unadjusted serum 1,25(OH)2D values, *dietary groups within a line differ 
significantly; line mean differs significantly relative to the B6 reference line, † for the 
0.5% Ca group, ^ for the 0.25% Ca group (p<0.05) (C) Adaptation of 1,25(OH)2D to low 







Figure 3.2  CYP27b1 and CYP24 enzymes are variable in a diverse population, but 
do not correlate to serum 1,25(OH)2D.  (A&C) CYP27b1 and CYP24 mRNA levels 
(arbitrary unit means ±SEM), *dietary groups within a line differ significantly; line 
mean differs significantly relative to the B6 reference line, † for the 0.5% Ca group, 
^ for the 0.25% Ca group (p<0.05, n=6-20 per diet per line) (B&D) Correlation of 
CYP27b1 and CYP24 to serum 1,25(OH)2D.  Solid line = regression line, 95% 







Figure 3.3  Serum vitamin D metabolites and the low dietary Ca adaptation of 
1,25(OH)2D are genetically variable in the BXD RI panel.  Z-scores were calculated for 
each BXD line mean on each diet population in reference to the combined population 










Figure 3.4  Composite Interval Mapping (CIM) identified multiple QTLs for 25(OH)D 
and 1,25(OH)2D. (A) 25(OH)D CIM results for (a) 0.5% Ca, (b) 0.25% Ca, and (c) Full 
combined diet population.  (B) 1,25(OH)2D CIM results for (a) 0.5% Ca, (b) 0.25% Ca, 
and (c) Full combined diet population, and (d) Adaptation to a low Ca diet.  Significance 
was determined separately for each data set by permutation (n=500), LOD cutoff shown 
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Intestinal calcium (Ca) is a vital component of the three-tissue axis (i.e. intestine, 
kidney, and bone) that maintains serum Ca homeostasis, particularly in times of low 
dietary Ca intake.  Natural genetic variation has been indicated to play a role in Ca 
absorption efficiency and its adaptation to a low Ca diet, but the genetic factors 
controlling this gene-by-diet interaction are not known.  We measured Ca absorption in 
male mice from 51 BXD recombinant inbred (RI) lines that were fed a normal (0.5%) or 
low (0.25%) Ca diet from 4-12 wks of age (n=8 per diet per line).  We used these data to 
map quantitative trait loci (QTLs) controlling Ca absorption efficiency as well as its 
adaptation to a low Ca diet.  We found that Ca absorption is genetically variable in the 
BXD RI panel with narrow sense heritability (h2) of 0.37 and 0.4 in the 0.5% and 0.25% 
Ca groups, respectively.  Ca absorption efficiency mapped to 12 QTLs in the mouse 
genome.  Diet-induced adaptation of Ca absorption ranged from -36% to 124% (h2=0.36).  
The three QTLs linked to diet-induced adaptation of Ca absorption did not overlap the 
twelve QTLs linked to Ca absorption efficiency on one or more diets.  Thus, genetic 
control of diet-induced adaptation of Ca absorption is independent of baseline efficiency.  
No known Ca absorption genes are found in these QTLs.  These results point to novel 







Intestinal calcium (Ca) absorption is critical for maintaining whole-body Ca 
homeostasis and protecting bone mass.(1)  Ca absorption is positively correlated to bone 
density in mice and humans.(2-4)  Higher Ca absorption efficiency during growth leads to 
higher bone deposition and decreased Ca absorption efficiency in adulthood is associated 
with increased fracture risk.(5-7)   Regulation of Ca absorption is sensitive to both genetic 
and environmental (e.g. diet) influences, but the genetic factors affecting Ca absorption, 
as well as its response to diet, are not well defined. 
 Ca absorption occurs through both a passive, paracellular component and an 
active, saturable transcellular pathway that is regulated in response to dietary Ca intake.  
During periods of habitual low dietary Ca intake serum Ca concentration drops, signaling 
release of parathyroid hormone (PTH) which upregulates the conversion of serum serum 
25 hydroxyvitamin D (25OHD) to the active hormone 1,25 dihydroxyvitamin D 
(1,25(OH)2D).  Genomic action of 1,25(OH)2D, through binding to the vitamin D 
receptor (VDR),  increases gene expression of the factors that mediate the facilitated 
diffusion model of intestinal Ca absorption.(8)  This model consists of Ca transport into 
the enterocyte by apical membrane channel transient receptor potential vanilloid member 
6 (TRPV6), movement of Ca across the cell bound to calbindin D9k (CaBPD9k), and 
extrusion across the basolateral membrane by the ATP dependent-plasma membrane Ca 
pump, PMCA1b.(8)  However, recent knockout models of TRPV6 and CaBPD9k indicate 
that the facilitated diffusion model is not the only mechanisms by which Ca absorption 




 Wide variation in Ca absorption efficiency (7-75%) has been observed in human 
populations.(10-12)  A large portion of this variation is likely due to natural genetic 
variation because environmental factors account for, at most, 25% of the variability.(13,14) 
Ca absorption efficiency has also been shown to differ between racial groups, a surrogate 
of genetic background.(6,15)  Similarly, racial differences exist in the adaptive response of 
Ca absorption to low dietary Ca intake and relationship to serum 1,25(OH)2D .
(10,15,16)   
Our group has previously characterized the significant genetic diversity of Ca absorption 
and its response to a low Ca diet present in a diverse population of mice.(4)  We now build 
on these observations using the BXD RI panel to map specific genomic regions (i.e. 
quantitative trait loci, QTLs) controlling intestinal Ca absorption efficiency and its 
adaptation to a low Ca diet.  This is the first study to map QTLs linked to Ca absorption 
under controlled and physiologically relevant conditions. 
 
4.3 Materials and Methods 
 
 Animal Models 4.3.1
The BXD recombinant inbred (RI) panel was used in this forward genetic linkage 
mapping study to identify QTL influencing intestinal Ca absorption efficiency.  In the 
BXD RI panel, each line is a unique recombination of the C57BL/6J (B6) and DBA/2J 
(DBA) parental genomes, but because each BXD line is inbred, each individual within a 
line is genetically identical.(17)  This advantage allows for biological replicates to test an 





 Experimental Design 4.3.2
Using the study design reported previously(4), male mice from the 51 BXD RI 
lines available from The Jackson Labs (Bar Harbor, ME) were obtained at 4 wks of age.  
At arrival, an equal number of mice from each line were randomly assigned to either a 
0.5% Ca (adequate) or 0.25% Ca (low) diet (AIN93G base with 200 IU vitamin D3/kg 
diet, Research Diets, New Brunswick, NJ) (n=8/diet/line).  Dietary Ca levels were chosen 
to meet the rodent dietary Ca requirement (0.5% Ca) or elicit an adaptive response to low 
Ca intake in serum 1,25(OH)2D (0.25% Ca).  Mice were maintained in a UV free 
environment (12 h light/dark cycle) and given food and water ad libitum.  At 12 wks of 
age mice were fasted overnight, anesthetized with an intraperitoneal injection of ketamine 
and xylazine, and Ca absorption measured by Ca45 radioisotope appearance in the serum 
10 min after an oral gavage test, as previously described.(4,18)  All animal experiments 
were approved by the Purdue University Animal Care and Use Committee. 
 
 Statistical Analysis 4.3.3
Data points with a z score in the extreme 2.5% of either end of a line/diet group 
distribution were removed as outliers.  Ca absorption was normalized using a natural log 
transformation and adherence to a normal distribution confirmed using the Anderson-
Darling test following transformation.  A significant covariate effect of femur length was 
determined by Pearson’s correlation and removed by simple linear regression.  Residuals 
were used for ANOVA and linkage mapping.(19)  ANOVA was used to test for the 
presence of significant main effects of genetic background (i.e. line) and diet as well as a 




to the low Ca diet was calculated as the percent difference between the raw phenotype 
value for an individual fed the 0.25% Ca diet and the raw line mean for the phenotype 
value from the 0.5% Ca diet, standardized to the line mean for the phenotype value from 
the 0.5% Ca diet, i.e.��0.25% 𝑥𝑖𝑗 − 0.5% ?̅?𝑗�/0.5% ?̅?𝑗�*100.  ANOVA was used to 
determine the effect of genetic background on this parameter.  Narrow-sense heritability 
(h2) was calculated using the r2 of a one-way ANOVA (main effect=line) for each 
diet/phenotype population.  Statistics were conducted using SAS Enterprise Guide 4.2 
(SAS Institute Inc., Cary, NC). 
 
 QTL Mapping 4.3.4
Marker information and BXD genotypes were downloaded from GeneNetwork 
(http://www.genenetwork.org/genotypes/BXD.geno) and the genetic location of each 
marker was updated using the Mouse Map Converter tool at the Jackson Labs Center for 
Genome Dynamics (http://cgd.jax.org/mousemapconverter/).(20)  Markers with duplicate 
genetic locations or perfectly correlated genotypes in our panel of BXD lines were 
removed.  The final genetic map for the 51 lines contained 1558 markers (the list is 
available on request). 
Composite interval mapping (CIM) was conducted using Windows QTL 
Cartographer v2.5_011 (http://statgen.ncsu.edu/qtlcart/WQTLCart.htm) with RI line 
means (n=51).  Forward selection identified 5 significant background markers.  CIM was 
carried out using a Haldane map function, 2 cM walking speed, and a 10 cM window.  
Each diet (0.5% or 0.25% Ca) group and the adaptation to low dietary Ca (1,25(OH)2D 




significance for each analysis.(21)  A Bayesian QTL mapping method using individual 
animal values was also used to validate CIM findings.  This method, as described in 
Zhang et al., accurately detects multiple QTL in a study with a large number of marker 
effects (p) and small sample size (n).(22)  Bayes factors were used as a measure of 
significance for the presence of a QTL.  Specifically, twice the natural log of the Bayes 
factor (2lnBF) was used as a test statistic because it scales similarly to an LOD score.(23,24) 
The strength of the 2lnBF test statistic was assessed according to the rubric defined by 
Kass and Raftery; “0-2 not worth a bare mention, 2-6 positive, 6-10 strong, >10 very 
strong”.(23)  Each diet population was mapped separately as well as included together in a 
full model to test the genetic main effect.  The use of these two QTL mapping methods 
allowed us to test for QTLs within the traditional framework, but still leverage our study 
design which contained biological replicates.  Results that were replicated among the 
analyses lent more confidence to the outcome and were prioritized for further study. 
 
 Bioinformatic Characterization 4.3.5
The QTL candidate region was defined using 1-LOD support intervals which 
approximate 95% confidence intervals.(25,26)  QTL candidate regions were populated with 
genome features including protein-coding genes, non-coding RNA genes, gene fragments, 
and unclassified genes from the Mouse Genome Informatics (MGI) database 
(http://www.informatics.jax.org/).(27) Genome-wide DNase1 hypersensitive site (HSS) 
data from the mouse ENCODE project was used to identify potential regulatory regions 




pad, genital fat pad, heart, kidney, large intestine, liver, lung, skeletal muscle, spleen, and 
brain) were merged using the UCSC Genome Browser. 
Gene locations were identified as the region from the first to last exon plus 5000 
bp region upstream of the gene coordinates for exon 1 (i.e. the proximal promoter region).  
Genomic regions that were identical by decent (IBD) between B6 and DBA were 
identified using the Mouse Phylogeny Viewer (http://msub.csbio.unc.edu/).(29)  Regions 
that were 100% IBD were eliminated from further consideration.  Genes that were less 
than 100% IBD and the remaining non-IBD regions were used to query for 
polymorphisms between B6 and DBA using the Mouse Phenome Database (MPD, 
http://phenome.jax.org/).  MPD annotations were used to categorize polymorphisms by 
gene attribute; intronic, mRNA un-translated region (5’ and 3’ UTR), promoter region 
(5000 bp upstream), and exon-associated (i.e. synonymous and non-synonymous codons, 
stop codons, splice sites, or frameshift mutations). HSS data was then overlaid with the 
polymorphisms present in the QTL region.  Reference amino acids and variants resulting 
from non-synonymous polymorphisms were categorized based on charge, polarity, size, 
and special cases using the classification set out by Zhang et al with modifications.(30)  
Amino acids were classified into only two categories for size: small; C, P, G, A, S, T, N, 
D, Q, E, I, L, M, and V; and large; R, H, K, F, W, and Y. Three special cases are 
considered; C, P, and G.  An amino acid substitution was considered deleterious if the 







 Ca Absorption Is Genetically Variable and Affected by a Gene-by-Diet 4.4.1
Interaction in the BXD RI Panel 
Ca absorption was significantly affected by the main effect of diet (p<0.0001, 
ANOVA) in the BXD RI panel.  Ca absorption was genetically variable as shown by a 
significant main effect of BXD line (p<0.0001, ANOVA).  The portion of variability in 
Ca absorption accounted for by additive genetic effects (i.e. narrow-sense heritability, h2) 
was 0.37 and 0.4 in the 0.5% and 0.25% Ca groups, respectively.  A significant gene-by-
diet interaction affecting Ca absorption was observed in the BXD RI panel (p=0.0008).  
This gene-by-diet interaction was investigated further by analyzing the calculated 
adaptation parameter.  Line means of the diet-induced adaptation of Ca absorption ranged 
from -36% to 124% across the BXD RI panel.  Low Ca adaptation of Ca absorption was 
significantly affected by genetic background (line main effect p<0.0001, ANOVA).  
Heritability of the adaptation of Ca absorption to a low Ca diet was estimated at 0.36. 
 
 Ca Absorption and Its Adaptation to a Low Ca Diet Map to Multiple, Independent 4.4.2
Genetic Loci 
Linkage mapping identified twelve QTLs that were significantly associated with 
Ca absorption efficiency in at least one mapping analysis conducted (Figure 4.1A-C, 
Table 4.1).  The diet-induced adaptation parameter mapped to three separate loci on chr 3, 
8, and 15 (Figure 4.1D, Table 4.1).  Detailed test statistics for QTL analyses can be found 




concordance among analyses and association with the adaptation parameter; CaAbs2 (chr 
4, 47cM), CaAbs5 (chr 7, 30 cM), CaAbs12 (chr3, 30 cM), CaAbs13 (chr 8, 24 cM), 
CaAbs14 (chr 15, 32 cM).  The characteristics of the 1-LOD support interval for each of 
these QTLs are listed in Table 4.3.  After IBD filtering the number of protein coding 
genes remaining in each region was 26, 220, 49, 67, and 57, respectively.  Further 
classification of functional polymorphisms at each locus is given in Table 4.4. Genes 
contained within the 1-LOD support interval are listed in Table 4.5. 
 
4.5 Discussion 
 Whole-body Ca homeostasis is maintained by absorption of dietary Ca in the 
intestine, reabsorption of urinary Ca by the kidney, and resorption of Ca from bone.(8)  
Sufficient dietary Ca intake is recommended for maintenance of bone health.  However, 
not every study sees a clear relationship between Ca intake and bone mineral density 
(BMD).(31-33)  Variability in intestinal Ca absorption efficiency provides a functional link 
between Ca intake and BMD.  Intestinal Ca absorption has been shown to be the critical 
element in maintaining Ca homeostasis and rescuing the low bone mass seen in VDR 
knockout mice.(1,18)  Low Ca absorption efficiency was shown to increase the fracture risk 
of postmenopausal women with low dietary Ca intake.(7)  This study highlights the 
importance of the physiological adaptive increase in Ca absorption in response to a low 
Ca diet in bone health.  Our group has previously shown that Ca absorption efficiency is 
significantly, positively correlated with femoral aBMD and trabecular bone volume 
fraction in a genetically diverse population of mice fed adequate or low Ca diets.(4)  




adaptive response to a low Ca diet is necessary for understanding the relationship 
between Ca intake and bone health.  We have conducted the first study to estimate the 
genetic component of intestinal Ca absorption and map it to linked loci in the mouse 
genome. 
 Our study demonstrates that intestinal Ca absorption and its adaptation to a 
habitual low Ca diet are influenced by both dietary environment and natural genetic 
variation in the BXD RI panel. The portion of the variability in Ca absorption that is due 
to genetic background (i.e. narrow sense heritability, h2) was 37% and 40% in the 0.5% 
and 0.25% Ca diet groups, respectively.  These heritability values are similar to those for 
other Ca homeostasis traits measured in the BXD RI panel.(See Ch. 3 and (34))  
Heritability of Ca absorption has not been estimated in human populations, but several 
lines of evidence suggest that genetics is a significant contributor to variability in 
intestinal Ca absorption efficiency in humans.  First, Ca absorption efficiency is observed 
to be widely variable in clinical studies.  Heaney et al. observed a range of 0.05-0.65 in 
true fractional calcium absorption (TFCA), even after adjustment for dietary calcium 
intake in four combined populations of postmenopausal, non-osteoporotic women.(35)  
Wolf et al. observed a range of 0.17-0.58 in TFCA.(13)  Environmental variables (e.g. 
dietary components, smoking, estrogen status) account for, at most, 25% of this 
variation(13,14), suggesting that genetic and gene-by-environment interactions account for 
the remainder. Additionally, Ca absorption efficiency has been observed to vary by racial 
background, which can be used as a surrogate for genetic background.  Specifically, 




girls.(6,16,36,37)  Chinese adolescent girls were also observed to have higher Ca absorption 
efficiency across a range of controlled calcium intakes.(15) 
 The adaptation of intestinal Ca absorption to a low Ca diet was also influenced by 
genetics in our study, as evidenced by a significant line-by-diet interaction influencing Ca 
absorption in the full BXD RIL panel.  Additionally, the calculated adaptation parameter 
was significantly variable across BXD lines and had a heritability of 36%.  Variation in 
the response of Ca absorption to a habitual low Ca intake has also been observed between 
racial groups.  Ca absorption assessed by balance over a range of Ca intakes indicated 
black adolescent girls increase Ca absorption efficiency on a low Ca diet, but white girls 
do not.(16)  In a separate study, Asian adolescents also exhibited an increase in Ca 
absorption efficiency on low Ca diets.(15) The genetic sources of this gene-by-diet 
interaction are unknown, but could greatly increase our ability to target individual dietary 
interventions.  Our study is the first forward genetic study to map the genetic variation 
controlling Ca absorption and its adaptation to a low Ca diet. 
Our results indicate that genetic control of Ca absorption is multifocal and 
complex.  Additionally, QTLs linked to diet-induced adaptation of Ca absorption did not 
overlap with other Ca absorption QTLs, indicating that regulation of the adaptive 
response is independent from regulation of baseline Ca absorption efficiency.  Identifying 
the causative variation driving these QTLs is a long and complex process that presents 
several challenges.(38)  It is helpful to first examine candidate genes that have previously 
been associated with the trait of interest, but because this is the first forward genetic 




comparison.  However, current models of intestinal Ca absorption provide possible a 
priori candidate genes.   
Facilitated diffusion is the most widely accepted model of intestinal Ca absorption 
and consists of transport of Ca across the apical membrane by TRPV6, escort across the 
enterocyte by CaBPD9k, and extrusion across the basolateral membrane by PMCA1b.(8)  
The facilitated diffusion model is up-regulated by the PTH-vitamin D endocrine axis in 
response to a low Ca diet.  Each of these genes is a target of 1,25(OH)2D genomic action, 
mediated through the vitamin D receptor (VDR).  Additionally, diffusion of Ca between 
enterocytes has been suggested to be regulated by tight junction proteins CLDN2 and 
CLDN12.(39)  Others have suggested that Ca absorption is linked to glucose absorption by 
the L-type Ca channel Cav1.3 (40)   
However, these genes are not located in, or near, the QTLs identified in this study.  
This finding could be due to the fact that the BXD population represents only a small 
portion (~20%) of the variance observed in the mouse genome.(41)  Thus, the BXD RI 
panel does not necessarily harbor genetic variation that alters known candidate gene 
function or regulation.  Instead, the variation inherent in the BXD RI panel that is driving 
Ca absorption QTLs represents novel factors or functions influencing Ca absorption. 
Recent findings support the hypothesis that novel regulation of intestinal Ca 
absorption and its adaptation to a low Ca diet remains to be found.  One such line of 
evidence is that current models do not explain the variation in Ca absorption observed in 
a diverse population mice (including the BXD parent lines).(4)  For example, in a study of 
11 inbred mouse lines, mRNA levels of facilitated diffusion model components were 




the variation in Ca absorption present in that population.(4)  CLDN2, CLDN12, and 
Cav1.3 were not significantly related to Ca absorption efficiency in that diverse mouse 
population.(4)  Similarly, Ca absorption efficiencies of TRPV6, CaBPD9k, and 
TRPV6/CaBPD9k double knockout mice were indistinguishable from wild-type mice on 
a high Ca diet.(9)  From these observations, genes proposed to mediate intestinal Ca 
absorption efficiency explain a limited amount, if any, of the variation observed in this 
trait.   
These studies also illustrate that the vitamin D endocrine axis does not fully 
explain the adaptation of intestinal Ca absorption to a low Ca diet.  Replogle et al. 
showed that subpopulations existed within the diverse 11 inbred line panel, including 
vitamin D-independent adaptors (i.e. lines that are able to increase Ca absorption 
efficiency without a corresponding increase in serum 1,25(OH)2D) and hyper-responders 
(i.e. those lines exhibiting a larger diet-induced increase in Ca absorption relative to the 
diet-induced increase in vitamin D), indicating multiple facets exist in the regulation of 
Ca absorption.(4)  When fed a low Ca diet, TRPV6 and TRPV6/CaBPD9k double 
knockout mice exhibited diminished, but not abolished, Ca absorption.(9)  In the present 
study only one Ca absorption QTL, CaAbs12 (chr 3, 30cM), coincided with a QTL our 
group had previously linked to serum 1,25(OH)2D levels (125D3, chr 3, 34cM) in the 
same BXD population (see Ch. 3).  This co-localization of genetic association between 
the two traits indicates a potential shared upstream regulator of 1,25(OH)2D serum level 
and intestinal Ca absorption adaptation.  However, the other fourteen QTLs linked to Ca 
absorption in this study do not track with those identified for vitamin D.  Taken together, 




dependent on variation in its accepted primary regulator, 1,25(OH)2D, or the facilitated 
diffusion model.   
Although a priori candidate genes and serum 1,25(OH)2D do not explain the 
majority of QTLs identified in this study, examination of genetic mapping of related 
biological functions can shed light on systems biology affecting Ca absorption.  Such is 
the case for CaAbs2 (chr 4, 47.35 cM), a QTL highly significant in 5 out of 6 analyses for 
intestinal Ca absorption efficiency.  Several bone-related traits map to this region of chr 4 
as well.  For example, femur cross-sectional area and cortical thickness mapped nearby 
(chr 4, 46.99 cM) in a heterogenous population derived from BALB/cJ, C3H/HeJ, B6, 
and DBA mice.(42)  Another study linked multiple vertebral trabecular bone traits (bone 
volume, bone volume fraction, trabecular thickness, and trabecular number) to this region 
of mouse chr 4 (45.76 cM) in an F2 cross between B6 and C3H/HeJ mice.(43) These 
results indicate that natural genetic variation which alters Ca absorption efficiency has 
downstream effects on bone health.  Additionally, a QTL for circulating thyroxine 
hormone was identified in this genomic region (chr 4, 46.99 cM) in the same 
heterogeneous mouse population as Volkman et al.(44)  Treatment with thyroid hormones 
has been shown to have a synergistic effect on 1,25(OH)2D-stimulated intestinal Ca 
absorption in cultured embryonic chick small intestine.(45)  Similarly, hyperthyroid 
hormone status has been shown to increase intestinal Ca transport in rats.(46)  These 
observations suggest that genetic variation affecting thyroid hormone is an upstream 
mediator of Ca absorption. 
Identifying causative variation driving novel Ca absorption QTLs presents 




indicated several functional candidates, but these were not supported by polymorphism 
data.  Thus, we are not able to definitively identify candidate genes driving the Ca 
absorption QTLs in this study.  Functional filtering of candidate genes included a wide 
variety of Gene Ontology (GO) terms, summarized by the following categories; ion 
homeostasis and transport, intestinal and renal integrity, intracellular trafficking, 
circulating factors, and regulation of gene expression.  This range of functions was 
chosen to encompass primary functions of genes involved in Ca homeostasis (i.e. TRPV6, 
CaBPD9k, and VDR) and general cellular ion homeostasis.  The addition of intracellular 
trafficking terms were included after a linkage mapping study of iron status implicated 
the gene Mon1a, as a novel factor influencing mineral homeostasis through intracellular 
trafficking.(47)  Several genes were highlighted by this functional filtering including: 
Zdhhc13, a magnesium transporter with palmitoyl acyltransferase activity(48); Rap2B, a 
Ras-like GTPase involved in the stimulation of phospholipase C-epsilon(49); potassium 
channels, Kcnab1 and Kcnk9; and Fat1, a protein in the cadherin superfamily that is 
involved in cell-cell junctions of podocytes in the renal glomerulus(50).  However, 
candidate genes from GO-term filtering contain no polymorphisms that would affect 
protein sequence or function (i.e. non-synonymous codon, splice site, frameshift, or stop 
codon changes).  Furthermore, with the exception of Kcnab1, the GO-term candidate 
genes did harbor polymorphisms within DNase1 HSS, suggesting that proximal 
regulation of mRNA expression of these genes is not variable in the BXD panel.  
However, this does not preclude the possibility that these QTLs represent distal 




required to elucidate how genetic variation in the BXD RI panel affects Ca absorption 
regulatory pathways. 
In summary, this is the first study to examine the genetic architecture of intestinal 
Ca absorption efficiency.  Using a genetically and environmentally controlled mouse 
model, we demonstrate that Ca absorption is significantly affected by genetic background.  
In addition, Ca absorption is influenced significantly by a gene-by-diet interaction in the 
BXD RI panel.  The degree to which Ca absorption adapts in response to a low Ca diet is 
affected by genetic background, and independent from the variation controlling baseline 
efficiency.  Our study demonstrates that there is still much unknown about genetic 
regulation of Ca absorption and its adaptation to a low Ca diet.  The QTLs found in the 
BXD RI panel represent novel variation affecting Ca absorption, but we are unable to 
definitively identify the causal variants at this time.  The QTLs identified in this study are 
an important first step in identifying novel factors or pathways influencing intestinal Ca 
absorption, and will serve as a foundation for identifying individuals who are most at-risk 
to the detrimental effects of habitual low Ca intake. 
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3 19.43 40.36 B6 
3 29.55 61.17 B6 
4 47.35 103.10 DBA 
5 40.50 76.57 B6 
5 77.12 139.20 DBA 
6 48.01 103.49 DBA 
7 30.25 46.50 B6 
8 23.69 38.00 B6 
8 31.43 64.09 DBA 
8 66.02 120.90 DBA 
9 43.70 79.17 DBA 
10 64.60 115.57 B6 
12 6.90 13.86 DBA 
15 32.31 71.81 B6 
17 49.98 79.56 DBA 
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1"Full" denotes the full combined diet population 
 2 "Adaptation" denotes the calculated adaptation to a low Ca 
diet 
3 CIM results are given in LOD, significance determined at 3.7 
(0.5% Ca), 3.4 (0.25% Ca), 2.5 (adaptation), and 3.8 (full) LOD. 












Table 4.3  Characteristics of Intestinal Ca Absorption QTL Candidate Regions 

























with genes  
CaAbs2 4 
100.6-
104.7 5744 46 26 11 271 152 78 
CaAbs5 7 41.1-49.0 20333 275 220 0 177 3 2 
CaAbs12 3 58.9-66.6 12608 79 49 8 761 260 116 
CaAbs13 8 36.1-47.7 31268 117 67 104 2406 2499 1677 
CaAbs14 15 69.1-75.9 17052 91 57 10 1017 362 362 
1 Polymorphisms 
2 Genome features include; protein-coding genes, non-coding RNA genes, gene fragments, and unclassified genes  










Table 4.4  Classification of Polymorphisms in Ca Absorption QTLs 




















CaAbs2 4 100.6-104.7 79 208 0 0 0 0 
CaAbs5 7 41.1-49.0 3 26 0 0 0 1 
CaAbs12 3 58.9-66.6 306 2683 17 8 9 24 
CaAbs13 8 36.1-47.7 2248 25855 129 104 42 201 
CaAbs14 15 69.1-75.9 507 3785 31 10 21 36 









Table 4.5  Candidate Genes Remaining for Ca Absorption QTLs After IBD Filtering 
CaAbs2 CaAbs5 CaAbs12 
Pde4b* Mrgpra6# Mrgprb13# Serp1 4930449A18Rik Gpr149* Vmn2r6 
4921539E11Rik* Mrgpra9 Mrgprb8# Eif2a Gm16527 Gm22433 Vmn2r7 
4930456L15Rik* Mrgpra1 Mrgprb1 6720482G16Rik Gm8298# Mme* Kcnab1* 
Oma1* Gm25326# Mrgprx2 Selt C130079G13Rik Gm24946 A330015K06Rik* 
4931409D07Rik# Mrgpra2a# Mrgprb2# Fam194a Aadacl2 Plch1 A730090N16Rik* 
Gm12718* Mrgpra3 Mrgprb3# AU022133 Aadac Gm23500# Ssr3* 
Gm23064* Gm22427# Zdhhc13 Siah2 Sucnr1 Gm24227 4931440P22Rik* 
Gm12720# Mrgpra4# Csrp3 4930593A02Rik Mbnl1 E130311K13Rik Gm22279 
Gm25877# Mrgprx1 E2f8* A930028O11Rik Gm19816# Slc33a1* Tiparp* 
Dab1* 2700078K13Rik# Gm2788* Fam188b2 P2ry1 Gm20031# Lekr1 
2900034C19Rik* Mrgprb5# Mrgpra2b Clrn1 B430305J03Rik Gm26850# Ccnl1 
  Mrgprb4 Ptpn5 Gm22491 Rap2b# Gmps Veph1* 
      Gm10071 Gm22162* Vmn2r1 Gm26442 
  
 
  Med12l 9330121J05Rik# Gm22165 Ptx3 
  
 
  Gm19372# Arhgef26* Vmn2r4   
      Gm5538 Dhx36* Vmn2r5   
Genes are listed in ascending order of 5' top strand start site bp location (given by Mouse Genome Informatics 
Database) 
1Genes containing at least one functional polymorphism are in bold  
  *indicates the presence of a polymorphism within a DNase1 HSS within the gene, # indicates a gene with no 
polymorphisms 
 





Table 4.5 (continued)  Candidate Genes Remaining for Ca Absorption QTLs After IBD Filtering 
CaAbs13 CaAbs14 
D8Ertd82e* 9330187G09Rik Gm26584# AY512931# Ufsp2# 4930573C08Rik 3100002H20Rik* 
3010031K01Rik* Gm23128 Slc7a2* Mtnr1a# Ankrd37# 4930504C09Rik* Peg13* 
4933430A20Rik* Tusc3* Pdgfrl* Gm6329# Lrp2bp# n-Tm3# Gm3150* 
Lonrf1* 6430500C12Rik Mtus1* F11# Snx25 Gm24232 Chrac1* 
Gm26150* Gm6213* B430010I23Rik* Klkb1# Gm24684# Gm23433 Ago2* 
6430573F11Rik* Msr1* Gm16192* Cyp4v3# Gm23030# Gm25330 Ptk2* 
Dlc1* Gm10682 Gm16193* Fam149a 4933411K20Rik# Gm24058 8030476L19Rik* 
9530004P13Rik* Fgf20* Fgl1* Tlr3# Gm15634# Gm23987 1700085D07Rik* 
9430047G12Rik* Micu3* Gm16348* Gm19634# Slc25a4# Gm19782 Mir151 
Gm19274* Zdhhc2* Pcm1* Sorbs2 Gm23812# Fam135b* Gm24787 
G630064G18Rik* Cnot7* Asah1* Gm23604# Gm24669# Gm22519# C130079B09Rik* 
AI429214* Vps37a* Frg1# Gm16351# Helt# Col22a1* Gm10362* 
Gm10683 Mtmr7* 2810404M03Rik D330022K07Rik Acsl1 Gm16308# Dennd3* 
1700016D18Rik* Gm2085* Zfp353# Gm16352# Mlf1ip# Gm19794 Slc45a4* 
Gm25126 Adam24* Gm23531# Gm25309# Ccdc111 Gm23217 1700010B13Rik* 
Sgcz* Adam25 Gm9908# Pdlim3 Casp3# Gm24390* Gpr20* 
n-Tl14# Adam20 Fat1 Ccdc110# Gm16675# A930009L07Rik Ptp4a3* 
Mir383 Adam39 Gm2366# 1700029J07Rik# Irf2# Kcnk9 Gm22106* 
  
   
  Trappc9* Mroh5* 
         Gm6569* 
Genes are listed in ascending order of 5' top strand start site bp location (given by Mouse Genome Informatics Database) 
1Genes containing at least one functional polymorphism are in bold  








Figure 4.1  Composite Interval Mapping (CIM) identified multiple QTLs affecting 
intestinal Ca absorption.  (A) 0.5% Ca, (B) 0.25% Ca, and (C) full combined diet 
population, and (D) adaptation to low Ca diet.  Significance was determined separately 




CHAPTER 5. FUTURE DIRECTIONS 
 
5.1 Research Summary 
Calcium (Ca) is a vital nutrient that is necessary for cell signaling and structural 
integrity of the skeleton.  Sufficient dietary Ca is recommended for maintenance of 
proper bone health.  Intestinal Ca absorption mediates the availability of dietary Ca for 
these purposes and is affected by environmental (e.g. dietary Ca) and genetic factors.  
This dissertation has focused on characterizing the natural genetic variation affecting 
intestinal Ca absorption efficiency and its primary regulator, serum 1,25(OH)2D under 
normal and low dietary Ca conditions. 
 The influence of genetics on Ca absorption has been suggested by observations 
between racial groups in clinical studies.(1,2) Serum 25(OH)D has been mapped in 
genome-wide association studies which pointed to regulation by genes known to function 
in vitamin D biology.(3)  Serum 1,25(OH)2D, although heritable, has not been 
significantly linked to genetic loci in the limited studies available.  These studies are 
limited by the fact that they cannot separate complex phenotypes such as Ca absorption 
and 1,25(OH)2D from the myriad physiological and environmental factors that are 
present in free-living human populations.  We have overcome this limitation by using 




We have clearly shown that natural genetic variation influences intestinal Ca 
absorption and vitamin D metabolites in these controlled animal models.  Intestinal Ca 
absorption, serum 25(OH)D, and serum 1,25(OH)2D were significantly variable across a 
diverse population of 11 inbred mouse lines (Ch. 2&3).  Interestingly, Ca absorption 
efficiency was significantly correlated to femoral trabecular bone volume in the 11 inbred 
mouse line population (Ch. 2).  These same parameters were also significantly affected 
by genetics in the BXD RI panel (Ch. 3&4).  The heritability of serum vitamin D 
metabolites compared well with estimates in human populations.  The study in Chapter 4 
is the first to estimate the heritability of Ca absorption, and shows it is moderately 
heritable (h2 = 0.37-0.4). 
Another goal of this dissertation was to examine if natural genetic variation 
influenced the adaptation of Ca homeostasis to the common dietary insufficiency of low 
Ca intake.  We observed that gene-by-diet interactions affect both 1,25(OH)2D and Ca 
absorption in the 11 inbred line population as well as the BXD RI panel.  This result 
concurs with observations between racial groups.(4,5)  Adaptation to a low Ca diet of both 
1,25(OH)2D and Ca absorption was significantly affected by genetic background in both 
mouse populations studied.  This is the first study to characterize the effect of genetic on 
1,25(OH)2D and Ca absorption using the relevant physiological condition of habitual low 
Ca intake. 
The study of 11 inbred mouse lines in Chapter 2 highlights that gaps remain in 
our understanding of intestinal Ca absorption and its regulation.  Regulation of intestinal 
Ca absorption is proposed to occur through low dietary Ca triggering an increase in 




Ca absorption.  This model holds true in B6 mice (the standard reference inbred line) and 
129S mice, but not in the other 9 lines studied.  In the whole population, variation in 
facilitated diffusion component mRNA levels explained only a small portion of variation 
in Ca absorption. Additionally, adaptation of Ca absorption was not fully explained by 
adaptation in 1,25(OH)2D.(Ch. 2)  These results, along with data from TRPV6 and 
CaBPD9k knockout mice(6), point to the existence of novel compensatory mechanisms of 
Ca absorption regulation. 
The forward genetics studies in Ch. 3&4 address these gaps in our knowledge and 
highlight novel variation affecting serum 1,25(OH)2D and intestinal Ca absorption.  
Linkage mapping results indicate that genetic control of each phenotype is multifocal and 
complex. The vitamin D receptor emerged as a candidate gene for one QTL affecting 
1,25(OH)2D.  Additionally, genetic regulation of each phenotype is, for the most part, 
independent.  For example, genetic regulation of serum 1,25(OH)2D was independent 
from that regulating serum 25(OH)D.  Genetic loci linked to Ca absorption did not 
overlap those linked to 1,25(OH)2D, with one exception, indicating that genetic 
regulation of these two traits is independent.  In both Ca absorption and 1,25(OH)2D, 
genetic regulation of the diet-induced adaptation was independent from that controlling 
baseline trait levels. 
These studies illustrate that natural genetic variation is a significant contributor to 
Ca absorption physiology.  We have mapped this genetic variation to specific loci in the 
mouse genome.  All but one QTL identified in these studies represent novel genetic 
factors affecting Ca absorption or vitamin D metabolites.  Although some promising 




identify the causal variants affecting our traits of interests.  Identification of the novel 
factors influencing Ca absorption and vitamin D metabolites will further our knowledge 
of these systems and inform personalized dietary recommendations in the future. 
 
5.2 Future Directions 
The studies in this dissertation have identified QTLs which affect intestinal Ca 
absorption and serum vitamin D metabolites. However, the causal variants driving these 
loci could not be definitively determined.  Therefore, future studies should focus on 
determining and characterizing the causative genes and variants.  This question could be 
addressed by physically narrowing the QTL region by fine-mapping in additional mouse 
crosses such as advanced intercross or congenic mouse lines.  However, I believe further 
analysis of the BXD RI panel by transcriptomics and transcription factor analysis will 
yield functional information for candidate gene identification. 
1.  Identify Genetic Loci Linked to Differential Gene Expression in the BXD Panel 
The majority of QTLs identified in Ch. 3&4 pointed to differences in gene 
regulation, rather than protein function.  Consequently, transcript levels of the candidate 
gene should differ across the BXD panel.  However, a large number of transcripts will be 
variable in this population but have no relationship to our phenotypes of interest, Ca 
absorption or serum vitamin D metabolites.  It is therefore necessary to link transcript 
variation to genetic variation, and these results can be compared to the Ca absorption and 
serum vitamin D metabolite QTLs identified in this dissertation.  This goal can be 




eQTL mapping uses mRNA transcript levels in a target tissue as linkage mapping 
phenotypes.  Specific, individual transcripts can be used but this requires prior knowledge 
of the gene affected.  The majority of QTLs identified for Ca absorption and vitamin D 
metabolites represent novel variation, so the target transcripts are not known.  Instead, I 
would recommend an “omic” approach that consists of measuring the transcriptome of a 
target tissue by microarray and mapping these results to the mouse genome.  eQTL 
mapping results can then be compared with Ca absorption and vitamin D metabolite 
results in two ways.  eQTLs that overlap with previous identified Ca homeostasis QTLs 
indicate that the target transcript may be influencing the Ca homeostatic trait of interest.  
Transcript values can also be correlated to the trait of interest (e.g. Ca absorption) across 
the BXD panel to confirm a direct relationship. Differential gene expression has been 
used successfully to identify candidate genes in bone-related QTLs.(7,8) 
eQTL mapping has advantages that will move the identification of causal genes in 
the BXD RI panel forward.  Primarily, eQTL mapping allows for identification of both 
cis and trans genetic loci affecting a given transcript level.  Cis regulation of a gene 
occurs at the gene’s location in the genome and may include alterations of the proximal 
promoter or intergenic enhancer elements.  Trans regulation occurs at a secondary site, 
far away (possibly even on different chromosomes) from the target gene’s coding 
sequence. Examples of trans regulation include distal regulatory elements and 
transcription factors.  This method can also be used to assess the gene-by-diet interaction 
observed in Ca absorption and 1,25(OH)2D by mapping the fold change of transcripts 




However, this method is limited by the small sample size of the BXD RI panel in 
relation to the large number of comparisons present in transcriptome analysis (>24,000).  
The choice of target tissue is also limiting.  Duodenal mRNA is an intuitive choice to 
relate to intestinal Ca absorption, and while it will likely be informative one must not 
assume is will be all-inclusive.  The choice of tissue for comparison to vitamin D 
metabolite QTLs is slightly more problematic because multiple tissues participate in 
vitamin D metabolism (e.g. parathyroid, liver, kidney, bone, and intestine).  I would 
profile and map the kidney transcriptome because it is downstream of most vitamin D 
metabolic signals, and is therefore most likely to harbor transcript variation in candidate 
genes. 
In summary, eQTLs represent genetic loci linked to differential gene expression 
of a specific transcript.  Our expected results would be overlap between an eQTL and a 
QTL identified in previous studies for Ca absorption or serum vitamin D metabolites.  
With this link between a specific transcript and our trait of interest we can begin to assign 
biological function to the variation driving Ca homeostasis QTLs and hypothesize 
specific interactions and pathways influencing our trait of interest. 
2.  Examine Transcription Factor Binding Sites for Variation 
 The results of eQTL mapping show genetic loci that contain genetic variation 
which influences a specific transcript level.  If those eQTLs co-localize in the genome 
and correlate to our traits of interest (i.e. “candidate eQTLs”), it gives an indication of 
what gene pathway may be affecting our traits of interest, but will not definitively 




altering candidate transcript levels, I would examine transcription factor binding sites 
within candidate eQTLs. 
 This process would begin with a detailed literature search for known transcription 
factors of the candidate transcript.  The genome sequence underlying candidate eQTLs 
will be queried for the binding motifs of these transcription factors.  Numerous software 
packages exist to retrieve binding motifs and align sequences.  Alternatively, 
transcription factor binding sites for 119 human transcription factors have been 
characterized genome-wide by ChIP-seq in 72 cell types as part of the ENCODE 
project.(9)  This dataset is valuable because it represents actual binding of transcription 
factors to the genome, but is limited by the selection of transcription factors and cells 
chosen by the investigators.  Transcription factor binding motifs are highly conserved 
evolutionarily(9), but data gathered from human sources would of course need to be 
confirmed in mouse.   
Following identification of transcription factor binding sites in candidate eQTLs, 
sequence polymorphisms between the BXD parent lines B6 and DBA will be examined.  
We would expect to see polymorphisms in the transcription factor binding sites which 
lead to dysregulation of the candidate transcript with downstream effects on our trait of 
interest.  Ultimately, the hypotheses generated from these genomic tools and databases 
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